odc-2022013100000740467/31Accelerated Filerfalse01/31/20222022Q2FALSExP1Y00000740462021-08-012022-01-310000074046us-gaap:CommonStockMember2022-01-31xbrli:shares0000074046us-gaap:CommonClassBMember2022-01-3100000740462022-01-31iso4217:USD00000740462021-07-310000074046us-gaap:CommonStockMember2021-07-31iso4217:USDxbrli:shares0000074046us-gaap:CommonClassBMember2021-07-3100000740462020-08-012021-01-310000074046us-gaap:CommonStockMember2021-08-012022-01-310000074046us-gaap:CommonStockMember2020-08-012021-01-310000074046us-gaap:CommonClassBMember2021-08-012022-01-310000074046us-gaap:CommonClassBMember2020-08-012021-01-3100000740462021-11-012022-01-3100000740462020-11-012021-01-310000074046us-gaap:CommonStockMember2021-11-012022-01-310000074046us-gaap:CommonStockMember2020-11-012021-01-310000074046us-gaap:CommonClassBMember2021-11-012022-01-310000074046us-gaap:CommonClassBMember2020-11-012021-01-310000074046us-gaap:CommonStockMember2020-10-310000074046us-gaap:TreasuryStockCommonMember2020-10-310000074046us-gaap:AdditionalPaidInCapitalMember2020-10-310000074046us-gaap:RetainedEarningsMember2020-10-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-10-310000074046us-gaap:NoncontrollingInterestMember2020-10-3100000740462020-10-310000074046us-gaap:CommonStockMember2020-11-012021-01-310000074046us-gaap:AdditionalPaidInCapitalMember2020-11-012021-01-310000074046us-gaap:RetainedEarningsMember2020-11-012021-01-310000074046us-gaap:TreasuryStockCommonMember2020-11-012021-01-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-11-012021-01-310000074046us-gaap:NoncontrollingInterestMember2020-11-012021-01-310000074046us-gaap:CommonStockMember2021-01-310000074046us-gaap:TreasuryStockCommonMember2021-01-310000074046us-gaap:AdditionalPaidInCapitalMember2021-01-310000074046us-gaap:RetainedEarningsMember2021-01-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-310000074046us-gaap:NoncontrollingInterestMember2021-01-3100000740462021-01-310000074046us-gaap:CommonStockMember2021-10-310000074046us-gaap:TreasuryStockCommonMember2021-10-310000074046us-gaap:AdditionalPaidInCapitalMember2021-10-310000074046us-gaap:RetainedEarningsMember2021-10-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-310000074046us-gaap:NoncontrollingInterestMember2021-10-3100000740462021-10-310000074046us-gaap:CommonStockMember2021-11-012022-01-310000074046us-gaap:AdditionalPaidInCapitalMember2021-11-012022-01-310000074046us-gaap:RetainedEarningsMember2021-11-012022-01-310000074046us-gaap:TreasuryStockCommonMember2021-11-012022-01-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-11-012022-01-310000074046us-gaap:NoncontrollingInterestMember2021-11-012022-01-310000074046us-gaap:CommonStockMember2022-01-310000074046us-gaap:TreasuryStockCommonMember2022-01-310000074046us-gaap:AdditionalPaidInCapitalMember2022-01-310000074046us-gaap:RetainedEarningsMember2022-01-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-310000074046us-gaap:NoncontrollingInterestMember2022-01-310000074046us-gaap:CommonStockMember2020-07-310000074046us-gaap:TreasuryStockCommonMember2020-07-310000074046us-gaap:AdditionalPaidInCapitalMember2020-07-310000074046us-gaap:RetainedEarningsMember2020-07-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-310000074046us-gaap:NoncontrollingInterestMember2020-07-3100000740462020-07-310000074046us-gaap:CommonStockMember2020-08-012021-01-310000074046us-gaap:AdditionalPaidInCapitalMember2020-08-012021-01-310000074046us-gaap:RetainedEarningsMember2020-08-012021-01-310000074046us-gaap:TreasuryStockCommonMember2020-08-012021-01-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-08-012021-01-310000074046us-gaap:NoncontrollingInterestMember2020-08-012021-01-310000074046us-gaap:CommonStockMember2021-07-310000074046us-gaap:TreasuryStockCommonMember2021-07-310000074046us-gaap:AdditionalPaidInCapitalMember2021-07-310000074046us-gaap:RetainedEarningsMember2021-07-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-310000074046us-gaap:NoncontrollingInterestMember2021-07-310000074046us-gaap:CommonStockMember2021-08-012022-01-310000074046us-gaap:AdditionalPaidInCapitalMember2021-08-012022-01-310000074046us-gaap:RetainedEarningsMember2021-08-012022-01-310000074046us-gaap:TreasuryStockCommonMember2021-08-012022-01-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-08-012022-01-310000074046us-gaap:NoncontrollingInterestMember2021-08-012022-01-310000074046srt:ScenarioPreviouslyReportedMember2020-11-012021-01-310000074046srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2020-11-012021-01-310000074046srt:ScenarioPreviouslyReportedMember2020-08-012021-01-310000074046srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2020-08-012021-01-310000074046odc:BusinesstoBusinessSegmentMembersrt:ScenarioPreviouslyReportedMember2020-11-012021-01-310000074046srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberodc:BusinesstoBusinessSegmentMember2020-11-012021-01-310000074046odc:BusinesstoBusinessSegmentMember2020-11-012021-01-310000074046odc:RetailAndWholesaleSegmentMembersrt:ScenarioPreviouslyReportedMember2020-11-012021-01-310000074046srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberodc:RetailAndWholesaleSegmentMember2020-11-012021-01-310000074046odc:RetailAndWholesaleSegmentMember2020-11-012021-01-310000074046odc:BusinesstoBusinessSegmentMembersrt:ScenarioPreviouslyReportedMember2020-08-012021-01-310000074046srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberodc:BusinesstoBusinessSegmentMember2020-08-012021-01-310000074046odc:BusinesstoBusinessSegmentMember2020-08-012021-01-310000074046odc:RetailAndWholesaleSegmentMembersrt:ScenarioPreviouslyReportedMember2020-08-012021-01-310000074046srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberodc:RetailAndWholesaleSegmentMember2020-08-012021-01-310000074046odc:RetailAndWholesaleSegmentMember2020-08-012021-01-310000074046us-gaap:UpFrontPaymentArrangementMember2022-01-310000074046us-gaap:UpFrontPaymentArrangementMember2021-07-310000074046us-gaap:UpFrontPaymentArrangementMember2021-08-012022-01-3100000740462020-03-272020-12-310000074046us-gaap:FairValueInputsLevel1Member2021-07-310000074046us-gaap:FairValueInputsLevel1Member2022-01-310000074046us-gaap:FairValueInputsLevel2Member2022-01-310000074046us-gaap:FairValueInputsLevel2Member2021-07-3100000740462020-08-012021-07-310000074046us-gaap:SeniorNotesMember2022-01-31xbrli:pure0000074046us-gaap:SeniorNotesMember2021-08-012022-01-310000074046us-gaap:PensionPlansDefinedBenefitMember2020-08-012021-07-310000074046us-gaap:PensionPlansDefinedBenefitMember2021-11-012022-01-310000074046us-gaap:PensionPlansDefinedBenefitMember2020-11-012021-01-310000074046us-gaap:PensionPlansDefinedBenefitMember2021-08-012022-01-310000074046us-gaap:PensionPlansDefinedBenefitMember2020-08-012021-01-310000074046us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-11-012022-01-310000074046us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-11-012021-01-310000074046us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-08-012022-01-310000074046us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-08-012021-01-310000074046us-gaap:PensionPlansDefinedBenefitMember2022-01-310000074046us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-31odc:segment0000074046odc:CatLitterMemberodc:BusinesstoBusinessSegmentMember2021-08-012022-01-310000074046odc:CatLitterMemberodc:BusinesstoBusinessSegmentMember2020-08-012021-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:CatLitterMember2021-08-012022-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:CatLitterMember2020-08-012021-01-310000074046odc:IndustrialandSportsMemberodc:BusinesstoBusinessSegmentMember2021-08-012022-01-310000074046odc:IndustrialandSportsMemberodc:BusinesstoBusinessSegmentMember2020-08-012021-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:IndustrialandSportsMember2021-08-012022-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:IndustrialandSportsMember2020-08-012021-01-310000074046odc:AgriculturalandHorticulturalMemberodc:BusinesstoBusinessSegmentMember2021-08-012022-01-310000074046odc:AgriculturalandHorticulturalMemberodc:BusinesstoBusinessSegmentMember2020-08-012021-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:AgriculturalandHorticulturalMember2021-08-012022-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:AgriculturalandHorticulturalMember2020-08-012021-01-310000074046odc:BusinesstoBusinessSegmentMemberodc:BleachingClayandFluidsPurificationMember2021-08-012022-01-310000074046odc:BusinesstoBusinessSegmentMemberodc:BleachingClayandFluidsPurificationMember2020-08-012021-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:BleachingClayandFluidsPurificationMember2021-08-012022-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:BleachingClayandFluidsPurificationMember2020-08-012021-01-310000074046odc:AnimalHealthandNutritionMemberodc:BusinesstoBusinessSegmentMember2021-08-012022-01-310000074046odc:AnimalHealthandNutritionMemberodc:BusinesstoBusinessSegmentMember2020-08-012021-01-310000074046odc:AnimalHealthandNutritionMemberodc:RetailAndWholesaleSegmentMember2021-08-012022-01-310000074046odc:AnimalHealthandNutritionMemberodc:RetailAndWholesaleSegmentMember2020-08-012021-01-310000074046odc:BusinesstoBusinessSegmentMember2021-08-012022-01-310000074046odc:RetailAndWholesaleSegmentMember2021-08-012022-01-310000074046odc:CatLitterMemberodc:BusinesstoBusinessSegmentMember2021-11-012022-01-310000074046odc:CatLitterMemberodc:BusinesstoBusinessSegmentMember2020-11-012021-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:CatLitterMember2021-11-012022-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:CatLitterMember2020-11-012021-01-310000074046odc:IndustrialandSportsMemberodc:BusinesstoBusinessSegmentMember2021-11-012022-01-310000074046odc:IndustrialandSportsMemberodc:BusinesstoBusinessSegmentMember2020-11-012021-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:IndustrialandSportsMember2021-11-012022-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:IndustrialandSportsMember2020-11-012021-01-310000074046odc:AgriculturalandHorticulturalMemberodc:BusinesstoBusinessSegmentMember2021-11-012022-01-310000074046odc:AgriculturalandHorticulturalMemberodc:BusinesstoBusinessSegmentMember2020-11-012021-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:AgriculturalandHorticulturalMember2021-11-012022-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:AgriculturalandHorticulturalMember2020-11-012021-01-310000074046odc:BusinesstoBusinessSegmentMemberodc:BleachingClayandFluidsPurificationMember2021-11-012022-01-310000074046odc:BusinesstoBusinessSegmentMemberodc:BleachingClayandFluidsPurificationMember2020-11-012021-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:BleachingClayandFluidsPurificationMember2021-11-012022-01-310000074046odc:RetailAndWholesaleSegmentMemberodc:BleachingClayandFluidsPurificationMember2020-11-012021-01-310000074046odc:AnimalHealthandNutritionMemberodc:BusinesstoBusinessSegmentMember2021-11-012022-01-310000074046odc:AnimalHealthandNutritionMemberodc:BusinesstoBusinessSegmentMember2020-11-012021-01-310000074046odc:AnimalHealthandNutritionMemberodc:RetailAndWholesaleSegmentMember2021-11-012022-01-310000074046odc:AnimalHealthandNutritionMemberodc:RetailAndWholesaleSegmentMember2020-11-012021-01-310000074046odc:BusinesstoBusinessSegmentMember2021-11-012022-01-310000074046odc:RetailAndWholesaleSegmentMember2021-11-012022-01-310000074046odc:BusinesstoBusinessSegmentMember2022-01-310000074046odc:BusinesstoBusinessSegmentMember2021-07-310000074046odc:RetailAndWholesaleSegmentMember2022-01-310000074046odc:RetailAndWholesaleSegmentMember2021-07-310000074046us-gaap:AllOtherSegmentsMember2022-01-310000074046us-gaap:AllOtherSegmentsMember2021-07-310000074046odc:A2006PlanMember2022-01-310000074046srt:MinimumMemberodc:A2006PlanMemberus-gaap:RestrictedStockMember2021-08-012022-01-310000074046srt:MaximumMemberodc:A2006PlanMemberus-gaap:RestrictedStockMember2021-08-012022-01-310000074046us-gaap:CommonStockMemberodc:A2006PlanMemberus-gaap:RestrictedStockMember2021-11-012022-01-310000074046us-gaap:CommonStockMemberodc:A2006PlanMemberus-gaap:RestrictedStockMember2020-11-012021-01-310000074046odc:A2006PlanMemberus-gaap:RestrictedStockMember2021-11-012022-01-310000074046odc:A2006PlanMemberus-gaap:RestrictedStockMember2020-11-012021-01-310000074046odc:A2006PlanMemberus-gaap:RestrictedStockMember2021-08-012022-01-310000074046odc:A2006PlanMemberus-gaap:RestrictedStockMember2020-08-012021-01-310000074046us-gaap:RestrictedStockMember2021-07-310000074046us-gaap:RestrictedStockMember2021-08-012022-01-310000074046us-gaap:RestrictedStockMember2022-01-310000074046us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-07-310000074046us-gaap:AccumulatedTranslationAdjustmentMember2021-07-310000074046us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-08-012022-01-310000074046us-gaap:AccumulatedTranslationAdjustmentMember2021-08-012022-01-310000074046us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-310000074046us-gaap:AccumulatedTranslationAdjustmentMember2022-01-310000074046srt:DirectorMember2021-11-012022-01-310000074046srt:DirectorMember2020-11-012021-01-310000074046srt:DirectorMember2021-08-012022-01-310000074046srt:DirectorMember2020-08-012021-01-310000074046srt:DirectorMember2022-01-310000074046srt:DirectorMember2021-07-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
(Mark One)
☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended January 31, 2022
or
| | | | | | | | |
☐ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from _____________ to ______________ | |
Commission File Number 001-12622
OIL-DRI CORPORATION OF AMERICA
(Exact name of the registrant as specified in its charter)
Delaware 36-2048898
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
410 North Michigan Avenue, Suite 400 60611-4213
Chicago, Illinois (Zip Code)
(Address of principal executive offices)
The registrant's telephone number, including area code: (312) 321-1515
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for at least the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | |
Large Accelerated Filer o | Accelerated Filer x | Non-accelerated Filer o | Smaller Reporting Company x | Emerging Growth Company o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, par value $0.10 per share | ODC | New York Stock Exchange |
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of January 31, 2022.
Common Stock – 5,287,013 Shares and Class B Stock – 2,045,415 Shares
CONTENTS
| | | | | | | | |
| | |
| PART I – FINANCIAL INFORMATION | |
| | Page |
Item 1: | | |
| | |
Item 2: | | |
| | |
| | |
| | |
Item 4: | | |
| | |
| PART II – OTHER INFORMATION | |
| | |
Item 1A: | Risk Factors | |
| | |
Item 2: | | |
| | |
Item 4: | | |
| | |
Item 6: | | |
| | |
| | |
FORWARD-LOOKING STATEMENTS
Certain statements in this report, including, but not limited to, those under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and those statements elsewhere in this report and other documents that we file with the Securities and Exchange Commission (“SEC”), contain forward-looking statements that are based on current expectations, estimates, forecasts and projections about our future performance, our business, our beliefs and our management’s assumptions. In addition, we, or others on our behalf, may make forward-looking statements in press releases or written statements, or in our communications and discussions with investors and analysts in the normal course of business through meetings, webcasts, phone calls and conference calls. Words such as “expect,” “outlook,” “forecast,” “would,” “could,” “should,” “project,” “intend,” “plan,” “continue,” “believe,” “seek,” “estimate,” “anticipate,” “may,” “assume,” “potential,” “strive,” and variations of such words and similar expressions are intended to identify such forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Such statements are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially, including, but not limited to, those described herein and in Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended July 31, 2021. Should one or more of these or other risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, intended, expected, believed, estimated, projected or planned. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except to the extent required by law, we do not have any intention or obligation to update publicly any forward-looking statements after the distribution of this report, whether as a result of new information, future events, changes in assumptions or otherwise.
TRADEMARK NOTICE
“Oil-Dri” and “Ultra-Clear” are registered trademarks of Oil-Dri Corporation of America.
PART I - FINANCIAL INFORMATION
ITEM 1. Financial Statements
OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Balance Sheet
(in thousands, except share and per share amounts)
| | | | | | | | | | | |
| (unaudited) | | |
ASSETS | January 31, 2022 | | July 31, 2021 |
Current Assets | | | |
Cash and cash equivalents | $ | 29,009 | | | $ | 24,591 | |
Accounts receivable, less allowance of $1,093 and $1,174 at January 31, 2022 and July 31, 2021, respectively | 45,970 | | | 40,923 | |
Inventories | 29,797 | | | 23,598 | |
Prepaid repairs | 6,454 | | | 6,088 | |
Prepaid expenses and other assets | 5,524 | | | 6,742 | |
Total Current Assets | 116,754 | | | 101,942 | |
| | | |
Property, Plant and Equipment | | | |
Cost | 272,980 | | | 274,825 | |
Less accumulated depreciation and amortization | (173,119) | | | (178,885) | |
Total Property, Plant and Equipment, Net | 99,861 | | | 95,940 | |
| | | |
Other Assets | | | |
Goodwill | 9,262 | | | 9,262 | |
Other intangibles, net of accumulated amortization of $471 and $385 at January 31, 2022 and July 31, 2021, respectively | 1,792 | | | 1,743 | |
Customer list, net of accumulated amortization of $7,464 and $7,321 at January 31, 2022 and July 31, 2021, respectively | 321 | | | 464 | |
Deferred income taxes | 2,066 | | | 2,096 | |
Operating lease right-of-use assets | 10,570 | | | 8,619 | |
Other | 6,588 | | | 7,500 | |
Total Other Assets | 30,599 | | | 29,684 | |
| | | |
Total Assets | $ | 247,214 | | | $ | 227,566 | |
The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Balance Sheet (continued)
(in thousands, except share and per share amounts)
| | | | | | | | | | | |
| (unaudited) | | |
LIABILITIES & STOCKHOLDERS’ EQUITY | January 31, 2022 | | July 31, 2021 |
Current Liabilities | | | |
Current maturities of notes payable | $ | 1,000 | | | $ | 1,000 | |
Accounts payable | 10,145 | | | 9,206 | |
Dividends payable | 1,845 | | | 1,865 | |
Operating lease liabilities | 2,080 | | | 2,036 | |
Accrued expenses | 23,802 | | | 24,883 | |
Total Current Liabilities | 38,872 | | | 38,990 | |
| | | |
Noncurrent Liabilities | | | |
Notes payable, net of unamortized debt issuance costs of $222 and $122 at January 31, 2022 and July 31, 2021, respectively | 32,778 | | | 7,878 | |
Deferred compensation | 5,060 | | | 4,370 | |
Pension and postretirement benefits | 4,253 | | | 4,922 | |
Long-term operating lease liabilities | 9,892 | | | 8,022 | |
Other | 3,068 | | | 4,152 | |
Total Noncurrent Liabilities | 55,051 | | | 29,344 | |
| | | |
Total Liabilities | 93,923 | | | 68,334 | |
| | | |
Stockholders’ Equity | | | |
Common Stock, par value $.10 per share, issued 8,667,968 shares at January 31, 2022 and 8,561,311 shares at July 31, 2021 | 867 | | | 856 | |
Class B Stock, par value $.10 per share, issued 2,397,056 shares at January 31, 2022 and 2,397,056 shares at July 31, 2021 | 240 | | | 240 | |
Additional paid-in capital | 50,220 | | | 48,271 | |
Retained earnings | 179,322 | | | 180,443 | |
Noncontrolling interest | (338) | | | (307) | |
Accumulated Other Comprehensive Loss: | | | |
| | | |
Pension and postretirement benefits | (4,375) | | | (4,428) | |
Cumulative translation adjustment | 217 | | | 311 | |
Total Accumulated Other Comprehensive Loss | (4,158) | | | (4,117) | |
Less Treasury Stock, at cost (3,380,955 Common and 351,641 Class B shares at January 31, 2022 and 3,192,702 Common and 346,491 Class B shares at July 31, 2021) | (72,862) | | | (66,154) | |
Total Stockholders’ Equity | 153,291 | | | 159,232 | |
| | | |
Total Liabilities & Stockholders’ Equity | $ | 247,214 | | | $ | 227,566 | |
The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Income
(in thousands, except for per share amounts)
| | | | | | | | | | | |
| (unaudited) |
| For the Six Months Ended January 31, |
| 2022 | | 2021 |
| | | |
Net Sales | $ | 169,670 | | | $ | 150,597 | |
Cost of Sales (1) | (140,266) | | | (115,128) | |
Gross Profit | 29,404 | | | 35,469 | |
Selling, General and Administrative Expenses (1) | (27,041) | | | (26,048) | |
Income from Operations | 2,363 | | | 9,421 | |
| | | |
Other Income (Expense) | | | |
Interest expense | (490) | | | (356) | |
Interest income | 17 | | | 40 | |
Other, net | 1,190 | | | 807 | |
Total Other Income, Net | 717 | | | 491 | |
| | | |
Income Before Income Taxes | 3,080 | | | 9,912 | |
Income Tax Expense | (524) | | | (1,675) | |
Net Income | 2,556 | | | 8,237 | |
Net Loss Attributable to Noncontrolling Interest | (31) | | | (46) | |
Net Income Attributable to Oil-Dri | $ | 2,587 | | | $ | 8,283 | |
| | | |
Net Income Per Share | | | |
Basic Common | $ | 0.38 | | | $ | 1.20 | |
Basic Class B Common | $ | 0.28 | | | $ | 0.89 | |
Diluted Common | $ | 0.37 | | | $ | 1.17 | |
Diluted Class B Common | $ | 0.28 | | | $ | 0.88 | |
Average Shares Outstanding | | | |
Basic Common | 5,095 | | | 5,149 | |
Basic Class B Common | 1,930 | | | 1,930 | |
Diluted Common | 5,211 | | | 5,265 | |
Diluted Class B Common | 1,966 | | | 1,972 | |
Dividends Declared Per Share | | | |
Basic Common | $ | 0.5400 | | | $ | 0.5200 | |
Basic Class B Common | $ | 0.4050 | | | $ | 0.3900 | |
(1) See Note 1 of the Notes to the unaudited Condensed Consolidated Financial Statements for further information about amounts included in this line item.
The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Comprehensive Income
(in thousands of dollars)
| | | | | | | | | | | |
| (unaudited) |
| For the Six Months Ended January 31, |
| 2022 | | 2021 |
| | | |
Net Income Attributable to Oil-Dri | $ | 2,587 | | | $ | 8,283 | |
| | | |
Other Comprehensive (Loss) Income: | | | |
| | | |
Pension and postretirement benefits (net of tax) | 53 | | | 329 | |
Cumulative translation adjustment | (94) | | | 408 | |
Other Comprehensive (Loss) Income | (41) | | | 737 | |
Total Comprehensive Income | $ | 2,546 | | | $ | 9,020 | |
The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Income
(in thousands, except for per share amounts)
| | | | | | | | | | | |
| (unaudited) |
| For the Three Months Ended January 31, |
| 2022 | | 2021 |
| | | |
Net Sales | $ | 87,210 | | | $ | 74,500 | |
Cost of Sales (1) | (71,624) | | | (57,811) | |
Gross Profit | 15,586 | | | 16,689 | |
Selling, General and Administrative Expenses (1) | (13,668) | | | (12,445) | |
Income from Operations | 1,918 | | | 4,244 | |
| | | |
Other Income (Expense) | | | |
Interest expense | (313) | | | (164) | |
Interest income | 8 | | | 15 | |
Other, net | 757 | | | 1,062 | |
Total Other Income, Net | 452 | | | 913 | |
| | | |
Income Before Income Taxes | 2,370 | | | 5,157 | |
Income Tax Expense | (409) | | | (869) | |
Net Income | 1,961 | | | 4,288 | |
Net Loss Attributable to Noncontrolling Interest | (41) | | | (11) | |
Net Income Attributable to Oil-Dri | $ | 2,002 | | | $ | 4,299 | |
| | | |
Net Income Per Share | | | |
Basic Common | $ | 0.29 | | | $ | 0.62 | |
Basic Class B Common | $ | 0.22 | | | $ | 0.47 | |
Diluted Common | $ | 0.28 | | | $ | 0.61 | |
Diluted Class B Common | $ | 0.22 | | | $ | 0.46 | |
Average Shares Outstanding | | | |
Basic Common | 5,077 | | | 5,150 | |
Basic Class B Common | 1,939 | | | 1,934 | |
Diluted Common | 5,186 | | | 5,253 | |
Diluted Class B Common | 1,965 | | | 1,967 | |
Dividends Declared Per Share | | | |
Basic Common | $ | 0.2700 | | | $ | 0.2600 | |
Basic Class B Common | $ | 0.2025 | | | $ | 0.1950 | |
(1) See Note 1 of the Notes to the unaudited Condensed Consolidated Financial Statements for further information about amounts included in this line item.
The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Comprehensive Income
(in thousands of dollars)
| | | | | | | | | | | |
| (unaudited) |
| For the Three Months Ended January 31, |
| 2022 | | 2021 |
| | | |
Net Income Attributable to Oil-Dri | $ | 2,002 | | | $ | 4,299 | |
| | | |
Other Comprehensive (Loss) Income: | | | |
Pension and postretirement benefits (net of tax) | 26 | | | 201 | |
Cumulative translation adjustment | (60) | | | 136 | |
Other Comprehensive (Loss) Income | (34) | | | 337 | |
Total Comprehensive Income | $ | 1,968 | | | $ | 4,636 | |
The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
OIL-DRI CORPORATION OF AMERICA
Consolidated Statements of Stockholders' Equity
(in thousands, except share amounts)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| For the Three Months Ended January 31 |
| (unaudited) |
| Number of Shares | | |
| Common & Class B Stock | | Treasury Stock | | Common & Class B Stock | | Additional Paid-In Capital | | Retained Earnings | | | | Treasury Stock | | Accumulated Other Comprehensive Loss | | Non-Controlling Interest | | Total Stockholders’ Equity |
Balance, October 31, 2020 | 10,919,617 | | | (3,453,239) | | | $ | 1,092 | | | $ | 45,779 | | | $ | 178,761 | | | | | $ | (63,253) | | | $ | (11,854) | | | $ | (209) | | | $ | 150,316 | |
Net Income (Loss) | — | | | — | | | — | | | — | | | 4,299 | | | | | — | | | — | | | (11) | | | 4,288 | |
Other Comprehensive Income | — | | | — | | | — | | | — | | | — | | | | | — | | | 337 | | | — | | | 337 | |
Dividends Declared | — | | | — | | | — | | | — | | | (1,795) | | | | | — | | | — | | | — | | | (1,795) | |
Purchases of Treasury Stock | — | | | (33,594) | | | — | | | — | | | — | | | | | (1,211) | | | — | | | — | | | (1,211) | |
Net issuance of stock under long-term incentive plans | 18,000 | | | (20,950) | | | 2 | | | 605 | | | — | | | | | (607) | | | — | | | — | | | — | |
Amortization of Restricted Stock | — | | | — | | | — | | | 506 | | | — | | | | | — | | | — | | | — | | | 506 | |
Balance, January 31, 2021 | 10,937,617 | | | (3,507,783) | | | $ | 1,094 | | | $ | 46,890 | | | $ | 181,265 | | | | | $ | (65,071) | | | $ | (11,517) | | | $ | (220) | | | $ | 152,441 | |
| | | | | | | | | | | | | | | | | | | |
Balance, October 31, 2021 | 11,033,024 | | | (3,618,510) | | | $ | 1,103 | | | $ | 49,377 | | | $ | 179,164 | | | | | $ | (68,922) | | | $ | (4,124) | | | $ | (297) | | | $ | 156,301 | |
Net Income (Loss) | — | | | — | | | — | | | — | | | 2,002 | | | | | — | | | — | | | (41) | | | 1,961 | |
Other Comprehensive Loss | — | | | — | | | — | | | — | | | — | | | | | — | | | (34) | | | — | | | (34) | |
Dividends Declared | — | | | — | | | — | | | — | | | (1,844) | | | | | — | | | — | | | — | | | (1,844) | |
Purchases of Treasury Stock | — | | | (113,236) | | | — | | | — | | | — | | | | | (3,910) | | | — | | | — | | | (3,910) | |
Net issuance of stock under long-term incentive plans | 32,000 | | | (850) | | | 4 | | | 26 | | | — | | | | | (30) | | | — | | | — | | | — | |
Amortization of Restricted Stock | — | | | — | | | — | | | 817 | | | — | | | | | — | | | — | | | — | | | 817 | |
Balance, January 31, 2022 | 11,065,024 | | | (3,732,596) | | | $ | 1,107 | | | $ | 50,220 | | | $ | 179,322 | | | | | $ | (72,862) | | | $ | (4,158) | | | $ | (338) | | | $ | 153,291 | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| For the Six Months Ended January 31 |
| (unaudited) |
| Number of Shares | | | | | | | | | | | | | | | | |
| Common & Class B Stock | | Treasury Stock | | Common & Class B Stock | | Additional Paid-In Capital | | Retained Earnings | | | | Treasury Stock | | Accumulated Other Comprehensive Loss | | Non-controlling Interest | | Total Stockholders' Equity |
Balance, July 31, 2020 | 10,886,405 | | | (3,426,046) | | | $ | 1,089 | | | $ | 44,993 | | | $ | 176,579 | | | | | $ | (62,269) | | | $ | (12,254) | | | $ | (174) | | | $ | 147,964 | |
Net Income (Loss) | — | | | — | | | — | | | — | | | 8,283 | | | | | — | | | — | | | (46) | | | 8,237 | |
Other Comprehensive Income | — | | | — | | | — | | | — | | | — | | | | | — | | | 737 | | | — | | | 737 | |
Dividends Declared | — | | | — | | | — | | | — | | | (3,597) | | | | | — | | | — | | | — | | | (3,597) | |
Purchases of Treasury Stock | — | | | (60,587) | | | — | | | — | | | — | | | | | (2,189) | | | — | | | — | | | (2,189) | |
Net issuance of stock under long-term incentive plans | 51,212 | | | (21,150) | | | 5 | | | 607 | | | — | | | | | (613) | | | — | | | — | | | (1) | |
Amortization of Restricted Stock | — | | | — | | | — | | | 1,290 | | | — | | | | | — | | | — | | | — | | | 1,290 | |
Balance, January 31, 2021 | 10,937,617 | | | (3,507,783) | | | $ | 1,094 | | | $ | 46,890 | | | $ | 181,265 | | | | | $ | (65,071) | | | $ | (11,517) | | | $ | (220) | | | $ | 152,441 | |
| | | | | | | | | | | | | | | | | | | |
Balance, July 31, 2021 | 10,958,367 | | | (3,539,193) | | | $ | 1,096 | | | $ | 48,271 | | | $ | 180,443 | | | | | $ | (66,154) | | | $ | (4,117) | | | $ | (307) | | | $ | 159,232 | |
Net Income (Loss) | — | | | — | | | — | | | — | | | 2,587 | | | | | — | | | — | | | (31) | | | 2,556 | |
Other Comprehensive Loss | — | | | — | | | — | | | — | | | — | | | | | — | | | (41) | | | — | | | (41) | |
Dividends Declared | — | | | — | | | — | | | — | | | (3,708) | | | | | — | | | — | | | — | | | (3,708) | |
Purchases of Treasury Stock | — | | | (179,003) | | | — | | | — | | | — | | | | | (6,201) | | | — | | | — | | | (6,201) | |
Net issuance of stock under long-term incentive plans | 106,657 | | | (14,400) | | | 11 | | | 496 | | | — | | | | | (507) | | | — | | | — | | | — | |
Amortization of Restricted Stock | — | | | — | | | — | | | 1,453 | | | — | | | | | — | | | — | | | — | | | 1,453 | |
Balance, January 31, 2022 | 11,065,024 | | | (3,732,596) | | | $ | 1,107 | | | $ | 50,220 | | | $ | 179,322 | | | | | $ | (72,862) | | | $ | (4,158) | | | $ | (338) | | | $ | 153,291 | |
The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Cash Flows
(in thousands)
| | | | | | | | | | | |
| (unaudited) |
| For the Six Months Ended January 31, |
CASH FLOWS FROM OPERATING ACTIVITIES | 2022 | | 2021 |
Net Income | $ | 2,556 | | | $ | 8,237 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | |
Depreciation and amortization | 6,773 | | | 7,065 | |
| | | |
Non-cash stock-based compensation | 1,453 | | | 1,290 | |
Deferred income taxes | 32 | | | 742 | |
Provision for bad debts and cash discounts | (59) | | | (38) | |
Loss on the disposals of property, plant and equipment | 265 | | | 12 | |
| | | |
(Increase) Decrease in assets: | | | |
Accounts receivable | (5,023) | | | (3,798) | |
Inventories | (6,236) | | | 412 | |
Prepaid expenses | 846 | | | (760) | |
Other assets | 634 | | | (266) | |
Increase (Decrease) in liabilities: | | | |
Accounts payable | 1,326 | | | (3,901) | |
Accrued expenses | (1,595) | | | (5,201) | |
Deferred compensation | 690 | | | 585 | |
Pension and postretirement benefits | (616) | | | (437) | |
Other liabilities | (985) | | | (857) | |
Total Adjustments | (2,495) | | | (5,152) | |
Net Cash Provided by Operating Activities | 61 | | | 3,085 | |
| | | |
CASH FLOWS FROM INVESTING ACTIVITIES | | | |
Capital expenditures | (10,574) | | | (7,598) | |
Proceeds from sale of property, plant and equipment | — | | | 3 | |
| | | |
| | | |
Net Cash Used in Investing Activities | (10,574) | | | (7,595) | |
| | | |
CASH FLOWS FROM FINANCING ACTIVITIES | | | |
Proceeds from issuance of notes payable | 25,000 | | | — | |
| | | |
Payment of debt issuance costs | (114) | | | — | |
Dividends paid | (3,728) | | | (3,606) | |
Purchases of treasury stock | (6,201) | | | (2,189) | |
| | | |
Net Cash Provided by (Used in) Financing Activities | 14,957 | | | (5,795) | |
Effect of exchange rate changes on Cash and Cash Equivalents | (26) | | | 123 | |
Net Increase (Decrease) in Cash and Cash Equivalents | 4,418 | | | (10,182) | |
Cash and Cash Equivalents, Beginning of Period | 24,591 | | | 40,890 | |
Cash and Cash Equivalents, End of Period | $ | 29,009 | | | $ | 30,708 | |
OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Cash Flows - Continued
(in thousands)
| | | | | | | | | | | |
| (unaudited) |
| For the Six Months Ended January 31, |
| 2022 | | 2021 |
Supplemental disclosures: | | | |
Interest payments, net of amounts capitalized | $ | 178 | | | $ | 198 | |
Income tax payments | $ | 155 | | | $ | 5,478 | |
Non-cash investing and financing activities: | | | |
Capital expenditures accrued, but not paid | $ | 835 | | | $ | 829 | |
Cash dividends declared and accrued, but not paid | $ | 1,845 | | | $ | 1,799 | |
The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
OIL-DRI CORPORATION OF AMERICA
Notes To Condensed Consolidated Financial Statements
(Unaudited)
1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements and the related notes are condensed and should be read in conjunction with the Consolidated Financial Statements and related notes for the fiscal year ended July 31, 2021 included in our Annual Report on Form 10-K filed with the SEC.
The unaudited Condensed Consolidated Financial Statements include the accounts of Oil-Dri Corporation of America and its subsidiaries. All significant intercompany transactions are eliminated. Except as otherwise indicated herein or as the context otherwise requires, references to “Oil-Dri,” the “Company,” “we,” “us” or “our” refer to Oil-Dri Corporation of America and its subsidiaries.
The unaudited Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals and reclassifications which are, in the opinion of management, necessary for a fair presentation of the statements contained herein. Operating results for the three and six months ended January 31, 2022 are not necessarily an indication of the results that may be expected for the fiscal year ending July 31, 2022.
Immaterial Correction of an Error in Previously Issued Financial Statements
Subsequent to the issuance of our Annual Report on Form 10-K for the fiscal year ended July 31, 2020, we identified an error in our historical financial statements related to the classification of certain costs as selling, general and administrative expenses relating to the production of our inventory that should be classified as cost of sales. These costs generally relate to our annual discretionary bonus and 401(k) employer match for our manufacturing employees, employee salaries for individuals in our support functions that spend a portion of their time related to our manufacturing operations such as IT, and other costs mostly related to consultants and outside services.
In accordance with FASB Accounting Standards Codification 250, Accounting Changes and Error Corrections, we evaluated the materiality of the error from both a quantitative and qualitative perspective, and concluded that the error was immaterial to our prior period interim and annual financial statements. Since the error was not material to any prior period interim or annual financial statements, no amendments to previously filed interim or annual periodic reports are required. Consequently, we have adjusted for these errors by revising our historical condensed consolidated financial statements presented herein. The revision to our historical condensed consolidated financial statements did not result in any impact to our consolidated net income.
The effects of the corrections to each of the individual affected line items in our unaudited Condensed Consolidated Statements of Income were as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| For the Three Months Ended January 31, 2021 |
| As Previously Reported | | Corrections | | As Corrected |
Cost of Sales | $ | (56,328) | | | $ | (1,483) | | | $ | (57,811) | |
| | | | | |
Selling, General and Administrative Expenses | $ | (13,928) | | | $ | 1,483 | | | $ | (12,445) | |
| | | | | |
| For the Six Months Ended January 31, 2021 |
| As Previously Reported | | Corrections | | As Corrected |
Cost of Sales | $ | (112,121) | | | $ | (3,007) | | | $ | (115,128) | |
| | | | | |
Selling, General and Administrative Expenses | $ | (29,055) | | | $ | 3,007 | | | $ | (26,048) | |
The related impacts to Inventory in our unaudited Condensed Consolidated Balance Sheet were not considered material and hence, were not adjusted.
The effects of the corrections to our Notes to the unaudited Condensed Consolidated Financial Statements for Operating Segments were as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| For the Three Months Ended January 31, 2021 |
| | | | | |
| Income |
| | | | | |
| As Previously Reported | | Corrections | | As Corrected |
| | | | | |
Business to Business Products | $ | 7,663 | | | $ | (550) | | | $ | 7,113 | |
| | | | | |
Retail and Wholesale Products | $ | 4,111 | | | $ | (933) | | | $ | 3,178 | |
| | | | | |
Corporate Expenses | $ | (7,530) | | | $ | 1,483 | | | $ | (6,047) | |
| | | | | |
| | | | | |
| For the Six Months Ended January 31, 2021 |
| | | | | |
| Income |
| | | | | |
| As Previously Reported | | Corrections | | As Corrected |
| | | | | |
Business to Business Products | $ | 15,859 | | | $ | (1,146) | | | $ | 14,713 | |
| | | | | |
Retail and Wholesale Products | $ | 8,589 | | | $ | (1,861) | | | $ | 6,728 | |
| | | | | |
Corporate Expenses | $ | (15,027) | | | $ | 3,007 | | | $ | (12,020) | |
Management Use of Estimates
The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses during the reporting period, as well as the related disclosures. Estimates and assumptions about future events cannot be made with certainty, including the potential impacts and duration of the novel coronavirus pandemic (“the coronavirus” or “COVID-19” or “the pandemic”) and its aftermath. All of our estimates and assumptions are revised periodically. Actual results could differ from these estimates.
Summary of Significant Accounting Policies
Our significant accounting policies, which are detailed in our Annual Report on Form 10-K for the fiscal year ended July 31, 2021, have not materially changed. The following is a description of certain of our significant accounting policies.
Trade Receivables. We recognize trade receivables when control of finished products are transferred to our customers. We record an allowance for doubtful accounts based on our historical experience and a periodic review of our accounts receivable, including a review of the overall aging of accounts, consideration of customer credit risk and analysis of facts and circumstances about specific customer accounts. A customer account is determined to be uncollectible when it is probable that a loss will be incurred after we have completed our internal collection procedures, including termination of shipments, direct customer contact and formal demand of payment.
Overburden Removal and Mining Costs. We mine sorbent materials on property that we either own or lease as part of our overall operations. A significant part of our overall mining cost is incurred during the process of removing the overburden (non-usable material) from the mine site, thus exposing the sorbent material used in a majority of our production processes. These stripping costs are treated as a variable inventory production cost and are included in cost of sales in the period they are incurred. We defer and amortize the pre-production overburden removal costs associated with opening a new mine.
Additionally, it is our policy to capitalize the purchase cost of land and mineral rights, including associated legal fees, survey fees and real estate fees. The costs of obtaining mineral patents, including legal fees and drilling expenses, are also capitalized. Pre-production development costs on new mines and any prepaid royalties that may be offset against future royalties due upon extraction of the minerals are also capitalized. All exploration related costs are expensed as incurred.
We perform ongoing reclamation activities during the normal course of our overburden removal. As overburden is removed from a mine site, it is hauled to previously mined sites and is used to refill older sites. This process allows us to continuously reclaim older mine sites and dispose of overburden simultaneously, therefore minimizing the costs associated with the reclamation process.
Leases. ASC 842, Leases, provides that a contract is, or contains, a lease if it conveys the right to control the use of an identified asset and, accordingly, a lease liability and a related right-of-use (“ROU”) asset is recognized at the commencement date on our consolidated balance sheet. As provided in ASC 842, we have elected not to apply these measurement and recognition requirements to short-term leases (i.e., leases with a term of 12 months or less). Short-term leases will not be recorded as ROU assets or lease liabilities on our consolidated balance sheet, and the related lease payments will be recognized in net earnings on a straight-line basis over the lease term. For leases other than short-term leases, the lease liability is equal to the present value of unpaid lease payments over the remaining lease term. The lease term may reflect options to extend or terminate the lease when it is reasonably certain that such options will be exercised. To determine the present value of the lease liability, we used an incremental borrowing rate, which is defined as the rate of interest we would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. The ROU asset is based on the corresponding lease liability adjusted for certain costs such as initial direct costs, prepaid lease payments and lease incentives received. Both operating and finance lease ROU assets are reviewed for impairment, consistent with other long-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a ROU asset is impaired, any remaining balance of the ROU asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life. After the lease commencement date, we evaluate lease modifications, if any, that could result in a change in the accounting for leases.
Certain of our leases provide for variable lease payments that vary due to changes in facts and circumstances occurring after the commencement date, other than the passage of time. Variable lease payments that are dependent on an index or rate (e.g., Consumer Price Index) are included in the initial measurement of the lease liability and the ROU asset. Variable lease payments that are not known at the commencement date and are determinable based on the performance or use of the underlying asset, are expensed as incurred. Our variable lease payments primarily include common area maintenance charges based on the percentage of the total square footage leased and the usage of assets, such as photocopiers.
Some of our contracts may contain lease components as well as non-lease components, such as an agreement to purchase services. As allowed under ASC 842, we have elected not to separate the lease components from non-lease components for all asset classes and we will not allocate the contract consideration to these components. This policy was applied to all existing leases upon adoption of ASC 842 and will be applied to new leases on an ongoing basis.
Revenue Recognition. We recognize revenue when performance obligations under the terms of the contracts with customers are satisfied. Our performance obligation generally consists of the promise to sell finished products to wholesalers, distributors and retailers or consumers and our obligations have an original duration of one year or less. Control of the finished products are transferred upon shipment to, or receipt at, customers' locations, as determined by the specific terms of the contract. We have completed our performance obligation when control is transferred and we recognize revenue accordingly. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Sales returns are not material nor are warranties and any related obligations.
We have an unconditional right to consideration under the payment terms specified in the contract upon completion of the performance obligation. We may require certain customers to provide payment in advance of product shipment. We recorded a liability for these advance payments of $523,000 and $256,000 as of January 31, 2022 and July 31, 2021, respectively. This liability is reported in Other within Accrued Expenses on the unaudited Condensed Consolidated Balance Sheet. Revenue recognized during the six months ended January 31, 2022 that was included in the liability for advance payments at the beginning of the period was $155,000.
We routinely commit to one-time or ongoing trade promotion programs directly with consumers, such as coupon programs, and with customers, such as volume discounts, cooperative marketing and other arrangements. We estimate and accrue the expected costs of these programs. These costs are considered variable consideration under ASC 606, Revenue from Contracts with Customers, and are netted against sales when revenue is recorded. The accruals are based on our best estimate of the amounts necessary to settle future and existing obligations on products sold as of the balance sheet date. To estimate these accruals, we rely on our historical experience of trade spending patterns and that of the industry, current trends and forecasted data.
Selling, General and Administrative Expenses. Selling, general and administrative expenses (“SG&A”) include salaries, wages and benefits associated with staff outside the manufacturing and distribution functions, all marketing related costs, any miscellaneous trade spending expenses not required to be included in net sales, research and development costs, depreciation
and amortization related to assets outside the manufacturing and distribution process and all other non-manufacturing and non-distribution expenses.
Other Current and Noncurrent Liabilities. On March 27, 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was signed into U.S. law. The CARES Act provides for, among other things, deferral of the employer portion of social security taxes incurred through the end of calendar 2020. As permitted by the CARES Act, we deferred approximately $2,300,000 in payroll taxes in calendar year 2020. $1,150,000 of the $2,300,000 was paid in the fourth quarter of calendar year 2021 and $1,150,000 will be paid in the fourth quarter of calendar year 2022. The remaining $1,150,000 accrual for these payroll taxes is included in Other within Accrued Expenses on the unaudited Condensed Consolidated Balance Sheet.
2. NEW ACCOUNTING PRONOUNCEMENTS AND REGULATIONS
Recently Issued Pronouncements
In March 2020, the FASB issued guidance under ASC 848, Reference Rate Reform. This guidance provides optional expedients and exceptions to account for debt, leases, contracts, hedging relationships and other transactions that reference LIBOR or another reference rate if certain criteria are met. The guidance is effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We have debt agreements that reference LIBOR and to the extent that those agreements are modified to replace LIBOR with another interest rate index, ASC 848 will allow us to account for the modification as a continuation of the existing contract without additional analysis. We are currently evaluating the potential effects of the adoption of this guidance on our Consolidated Financial Statements.
In June 2016, the FASB issued guidance under ASC 326, Financial Instruments-Credit Losses, which requires companies to utilize an impairment model for most financial assets measured at amortized cost and certain other financial instruments, which include trade and other receivables, loans and held-to-maturity debt securities, to record an allowance for credit risk based on expected losses rather than incurred losses. In addition, this new guidance changes the recognition method for credit losses on available-for-sale debt securities, which can occur as a result of market and credit risk, as well as additional disclosures. In general, this guidance will require modified retrospective adoption for all outstanding instruments that fall under this guidance. This guidance is effective for our first quarter of fiscal year 2023. We are currently evaluating the impact of the adoption of this requirement on our Consolidated Financial Statements.
There have been no other accounting pronouncements issued but not yet adopted by us which are expected to have a material impact on our Consolidated Financial Statements.
3. INVENTORIES
The composition of inventories is as follows (in thousands):
| | | | | | | | | | | |
| January 31, 2022 | | July 31, 2021 |
Finished goods | $ | 15,702 | | | $ | 14,179 | |
Packaging | 7,877 | | | 5,084 | |
Other | 6,218 | | | 4,335 | |
Total Inventories | $ | 29,797 | | | $ | 23,598 | |
Inventories are valued at the lower of cost (first-in, first-out) or net realizable value. Inventory costs include the cost of raw materials, packaging supplies, labor and other overhead costs. The inventory obsolescence reserve values at January 31, 2022 and July 31, 2021 were $541,000 and $641,000, respectively. Inventories, in all categories, have increased due to a combination of rising costs and building inventory levels for anticipated demand.
4. FAIR VALUE MEASUREMENTS
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized into categories based on the lowest level of input that is significant to the fair value measurement. The categories in the fair value hierarchy are as follows:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs for similar assets or liabilities or valuation models whose inputs are observable, directly or indirectly.
Level 3: Unobservable inputs.
Cash equivalents are primarily money market mutual funds classified as Level 1. We had no cash equivalents as of January 31, 2022 and July 31, 2021.
Balances of accounts receivable and accounts payable approximated their fair values at January 31, 2022 and July 31, 2021 due to the short maturity and nature of those balances.
Notes payable are reported at the face amount of future maturities. The estimated fair value of notes payable, including current maturities, was $36,985,000 and $10,231,000 as of January 31, 2022 and July 31, 2021, respectively, and are classified as Level 2. The fair value was estimated using the exit price notion of fair value.
We apply fair value techniques on at least an annual basis associated with: (1) valuing potential impairment loss related to goodwill, trademarks and other indefinite-lived intangible assets and (2) valuing potential impairment loss related to long-lived assets. See Note 5 of the Notes to the unaudited Condensed Consolidated Financial Statements for further information about goodwill and other intangible assets.
5. GOODWILL AND OTHER INTANGIBLE ASSETS
Intangible assets, other than goodwill, include trademarks, patents, customer lists and product registrations. Intangible amortization expense was $138,000 and $150,000 in the second quarter of fiscal years 2022 and 2021, respectively. Intangible amortization expense was $253,000 and $305,000 in the first six months of fiscal years 2022 and 2021, respectively. Estimated intangible amortization for the remainder of fiscal year 2022 is $233,000. Estimated intangible amortization for the next five fiscal years is as follows (in thousands):
| | | | | |
2023 | $ | 262 | |
2024 | $ | 126 | |
2025 | $ | 102 | |
2026 | $ | 99 | |
2027 | $ | 96 | |
We have one acquired trademark recorded at a cost of $376,000 that was determined to have an indefinite life and is not amortized.
We performed our annual goodwill impairment analysis in the fourth quarter of fiscal year 2021 and no impairment was identified. There have been no triggering events that would indicate a new impairment analysis is needed. Although we have not identified any triggering events relating to goodwill or our intangibles, the ultimate effects of COVID-19 could change this assessment in the future.
6. ACCRUED EXPENSES
Accrued expenses is as follows (in thousands):
| | | | | | | | | | | | | | |
| | January 31, 2022 | | July 31, 2021 |
Salaries, Wages, Commissions and Employee Benefits | | $ | 9,097 | | | $ | 10,806 | |
Trade promotions and advertising | | 2,178 | | | 1,653 | |
Freight | | 3,034 | | | 2,845 | |
Real Estate Tax | | 228 | | | 1,002 | |
Other | | 9,265 | | | 8,577 | |
| | $ | 23,802 | | | $ | 24,883 | |
The decrease in salaries, wages, commissions and employee benefits relates primarily to the payment of annual discretionary bonuses during the first quarter of fiscal year 2022. Changes in the accrual for trade promotions and advertising as well as real estate taxes differ due to timing. The accrual for other is higher at January 31, 2022 than July 31, 2021 due to an increase in accrual for rising natural gas costs and timing of certain plant purchases and expenses.
7. OTHER CONTINGENCIES
We are party to various legal actions from time to time that are ordinary in nature and incidental to the operation of our business, including ongoing litigation. While it is not possible at this time to determine with certainty the ultimate outcome of these or other lawsuits, we believe that none of the pending proceedings will have a material adverse effect on our business, financial condition, results of operations or cash flows. In June 2020, the Company received notice from a former service provider alleging a breach of contract regarding the payment of a contingency fee. Such party subsequently, in July 2020, filed a lawsuit seeking to require the Company to participate in binding mediation regarding this matter. Although we believe this claim to be without merit, as of July 31, 2020, we have determined a reasonable estimate of this liability within a range, with no amount within that range being a better estimate than any other amount, and have therefore recorded that estimate in Other within Accrued expenses. There have been no changes during fiscal 2021 or the three months ended January 31, 2022 that would have changed this estimate. We believe that any loss related to this matter is unlikely to be material. However, the outcome of this legal matter is subject to significant uncertainties. The ability to predict the ultimate outcome of this legal matter involves judgments, estimates and inherent uncertainties. The actual outcome could differ materially from management’s estimates.
8. DEBT
Effective December 16, 2021 (the “Effective Date”), we entered into Amendment No. 1 (the “Amendment”) to the Amended and Restated Note Purchase and Private Shelf Agreement (the “Note Agreement”) with PGIM, Inc. (“Prudential”) and certain existing noteholders affiliated with Prudential named therein.
The Amendment provides that, among other things, an excess leverage fee will be applied to the interest rate applicable to the outstanding daily average principal amount of Notes issued on or after December 15, 2021 as follows: (i) an additional 0.25% in the event the Net Leverage Ratio (as defined in the Amendment) is 2.00:1.00 or greater as of the last day of any fiscal quarter, or (ii) an additional 1.00% in the event that the Net Leverage Ratio is greater than 2.50:1.00 as of the last day of any fiscal quarter.
Concurrent with entering into the Amendment, we issued $25,000,000 in aggregate principal amount of Series C Senior Notes (the “Series C Notes”). The Series C Notes bear interest at an annual rate of 3.25% (subject to the application of the excess leverage fee in the event the Net Leverage Ratio exceeds certain thresholds as described above) and will mature on December 16, 2031. Annual principal payments of $5,000,000 are due December 16 of each fiscal year beginning in 2027 and ending in 2031. Interest is payable semi-annually beginning June 16, 2022.
9. LEASES
We have operating leases primarily for real estate properties, including corporate headquarters, customer service and sales offices, manufacturing and packaging facilities, warehouses, and research and development facilities, as well as for rail tracks, railcars and office equipment. Certain of our leases for a shared warehouse and office facility, rail track and railcars have options to extend which we are reasonably certain we will exercise and, accordingly, have been considered in the lease term used to recognize our ROU assets and lease liabilities. To determine the present value of the lease liability, we use an incremental borrowing rate, which is defined as the rate of interest that the Company would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. Further information about our accounting policy for leases is included in Note 1 of the Notes to the unaudited Condensed Consolidated Financial Statements.
We have no material finance leases, and variable costs for operating leases are immaterial for the three and six months ended January 31, 2022. Operating lease costs are included in Cost of Sales or SG&A expenses based on the nature of the lease. The following table summarizes total lease costs for our operating leases (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | |
| For the Three Months Ended January 31, | | For the Six Months Ended January 31, | |
| | |
| 2022 | | 2021 | | 2022 | | 2021 | |
Operating Lease Cost | | | | | | | | |
Operating lease cost | $ | 718 | | | $ | 657 | | | $ | 1,352 | | | $ | 1,352 | | |
Short-term operating lease cost | 159 | | | 176 | | | 308 | | | 362 | | |
Supplemental cash flow information related to leases was as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| For the Three Months Ended January 31, | | For the Six Months Ended January 31, |
| |
| 2022 | | 2021 | | 2022 | | 2021 |
Other Information | | | | | | | |
Cash paid for amounts included in the measurement of lease liabilities: | | | | | | | |
Operating cash flows from operating leases | $ | 636 | | | $ | 567 | | | $ | 1,197 | | | $ | 1,169 | |
| | | | | | | |
Operating lease ROU assets and operating lease liabilities are separately presented on the unaudited Condensed Consolidated Balance Sheet, excluding leases with an initial term of twelve months or less. Other supplemental balance sheet information related to leases was as follows:
| | | | | | | | | | | |
| January 31, 2022 | | July 31, 2021 |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Weighted-average remaining lease term - operating leases | 8.8 years | | 9.1 years |
| | | |
| | | |
Weighted-average discount rate - operating leases | 3.86% | | 3.88% |
The following table summarizes scheduled minimum future lease payments due within twelve months for operating leases with terms longer than one year for which cash flows are fixed and determinable as of January 31, (in thousands):
| | | | | | |
| | |
| | |
2022 | $ | 1,294 | | |
2023 | 2,042 | | |
2024 | 1,884 | | |
2025 | 1,751 | | |
2026 | 1,467 | | |
Thereafter | 5,665 | | |
Total | 14,103 | | |
Less: imputed interest | (2,131) | | |
Net lease obligation | $ | 11,972 | | |
10. PENSION AND OTHER POSTRETIREMENT BENEFITS
Pension and Postretirement Health Benefits
The Oil-Dri Corporation of America Pension Plan (“Pension Plan”) is a defined benefit pension plan for eligible salaried and hourly employees. Pension benefits are based on a formula of years of credited service and levels of compensation or stated amounts for each year of credited service. On January 9, 2020, we amended the Pension Plan to freeze participation, all future benefit accruals and accrual of benefit service, including consideration of compensation increases, effective March 1, 2020. Consequently, the Pension Plan is closed to new participants and current participants no longer earn additional benefits on or after March 1, 2020. On May 4, 2021, we purchased a pension annuity which settled $8.5 million of projected benefit obligations and recognized a settlement loss of approximately $0.6 million due to the annuity purchase.
The components of net periodic pension and postretirement health benefit costs were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits |
| (in thousands) |
| For the Three Months Ended January 31, | | For the Six Months Ended January 31, |
| 2022 | | 2021 | | 2022 | | 2021 |
Interest cost | $ | 266 | | | $ | 583 | | | $ | 534 | | | $ | 583 | |
Expected return on plan assets | (646) | | | (1,444) | | | (1,293) | | | (1,444) | |
Amortization of: | | | | | | | |
Other actuarial loss | 35 | | | 265 | | | 72 | | | 435 | |
Net periodic benefit cost | $ | (345) | | | $ | (596) | | | $ | (687) | | | $ | (426) | |
| | | | | | | |
| Postretirement Health Benefits |
| (in thousands) |
| For the Three Months Ended January 31, | | For the Six Months Ended January 31, |
| 2022 | | 2021 | | 2022 | | 2021 |
Service cost | $ | 28 | | | $ | 34 | | | $ | 61 | | | $ | 69 | |
Interest cost | 13 | | | 12 | | | 29 | | | 25 | |
Amortization of: | | | | | | | |
Other actuarial loss | — | | | 2 | | | — | | | 2 | |
Prior service costs | (2) | | | (2) | | | (3) | | | (3) | |
Net periodic benefit cost | $ | 39 | | | $ | 46 | | | $ | 87 | | | $ | 93 | |
The non-service cost components of net periodic benefit cost are included in Other Income (Expense) in the line item Other, net on the unaudited Condensed Consolidated Statements of Income.
The Pension Plan is funded based upon actuarially determined contributions that take into account the amount deductible for income tax purposes, the normal cost and the minimum contribution required and the maximum contribution allowed under applicable regulations. We were not required to make, and did not voluntarily make, a contribution to the Pension Plan during the first six months of fiscal year 2022. We have no minimum funding requirements for the remainder of fiscal year 2022.
The postretirement health plan is an unfunded plan. We pay insurance premiums and claims from our assets.
Assumptions used in the previous calculations were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits | | Postretirement Health Benefits |
| For the Three and Six Months Ended January 31, |
| 2022 | | 2021 | | 2022 | | 2021 |
Discount rate for net periodic benefit cost | 2.57 | % | | 2.14 | % | | 2.10 | % | | 1.63 | % |
Rate of increase in compensation levels | — | % | | — | % | | — | | | — | |
Long-term expected rate of return on assets | 6.50 | % | | 6.50 | % | | — | | | — | |
The medical cost trend assumption for postretirement health benefits was 7.05%. The graded trend rate is expected to decrease to an ultimate rate of 4.50% in fiscal year 2038.
Supplemental Executive Retirement Plan
The Oil-Dri Corporation of America Supplemental Executive Retirement Plan (“SERP”) provided certain retired participants in the Pension Plan with the amount of benefits that would have been provided under the Pension Plan but for: (1) the limitations on benefits imposed by Section 415 of the Internal Revenue Code (“Code”) and/or (2) the limitation on compensation for purposes of calculating benefits under the Pension Plan imposed by Section 401(a)(17) of the Code. The SERP liability was actuarially determined at the end of each fiscal year using assumptions similar to those used for the Pension Plan.
On January 9, 2020, we amended the SERP to freeze participation and any excess benefit, supplemental benefit or additional benefit effective March 1, 2020. Consequently, the SERP was closed to new participants and current participants no longer earned additional benefits on or after March 1, 2020. The SERP was terminated effective June 30, 2020 and all participants were paid in the form of one lump sum in July 2021.
11. OPERATING SEGMENTS
We have two operating segments: (1) Business to Business Products Group and (2) Retail and Wholesale Products Group. These operating segments are managed separately and each segment's major customers have different characteristics. The Retail and Wholesale Products Group customers include: mass merchandisers; wholesale clubs; drugstore chains; pet specialty retail outlets; dollar stores; retail grocery stores; e-commerce retailers; distributors of industrial cleanup and automotive products; environmental service companies; and sports field product users. The Business to Business Products Group customers include: processors and refiners of edible oils, petroleum-based oils and biodiesel fuel; manufacturers of animal feed and agricultural chemicals; distributors of animal health and nutrition products; and marketers of consumer products. Our operating segments are also our reportable segments. The accounting policies of the segments are the same as those described in Note 1 of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2021.
Net sales for our principal products by segment are as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Business to Business Products Group | | Retail and Wholesale Products Group |
| For the Six Months Ended January 31, |
Product | 2022 | | 2021 | | 2022 | | 2021 |
Cat Litter | $ | 9,327 | | | $ | 7,612 | | | $ | 89,141 | | | $ | 81,879 | |
Industrial and Sports | — | | | — | | | 17,940 | | | $ | 13,972 | |
Agricultural and Horticultural | 13,519 | | | 12,033 | | | — | | | — | |
Bleaching Clay and Fluids Purification | 29,540 | | | 25,406 | | | 1,036 | | | $ | 941 | |
Animal Health and Nutrition | 9,167 | | | 8,754 | | | — | | | — | |
Net Sales | $ | 61,553 | | | $ | 53,805 | | | 108,117 | | | $ | 96,792 | |
Net sales for our principal products by segment are as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| Business to Business Products Group | | Retail and Wholesale Products Group |
| For the Three Months Ended January 31, |
Product | 2022 | | 2021 | | 2022 | | 2021 |
Cat Litter | $ | 4,691 | | | $ | 3,736 | | | $ | 45,246 | | | $ | 41,085 | |
Industrial and Sports | — | | | — | | | 8,820 | | | 6,710 | |
Agricultural and Horticultural | 7,311 | | | 5,046 | | | — | | | — | |
Bleaching Clay and Fluids Purification | 15,035 | | | 12,765 | | | 520 | | | 422 | |
Animal Health and Nutrition | 5,587 | | | 4,736 | | | — | | | — | |
Net Sales | $ | 32,624 | | | $ | 26,283 | | | $ | 54,586 | | | $ | 48,217 | |
| | | | | | | |
We do not rely on any segment asset allocations and we do not consider them meaningful because of the shared nature of our production facilities; however, we have estimated the segment asset allocations below for those assets for which we can reasonably determine. The unallocated asset category is the remainder of our total assets. The asset allocation is estimated and is not a measure used by our chief operating decision maker about allocating resources to the operating segments or in assessing their performance.
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Assets |
| | | | | January 31, 2022 | | July 31, 2021 |
| | | | | (in thousands) |
Business to Business Products Group | | $ | 73,041 | | | $ | 69,023 | |
Retail and Wholesale Products Group | | 111,332 | | | 103,268 | |
Unallocated Assets | | 62,841 | | | 55,275 | |
Total Assets | | $ | 247,214 | | | $ | 227,566 | |
Net sales and operating income for each segment are provided below. The corporate expenses line includes certain unallocated expenses, including primarily salaries, wages and benefits, purchased services, rent, utilities and depreciation and amortization associated with corporate functions such as research and development, information systems, finance, legal, human resources and customer service. Corporate expenses also include the estimated annual incentive plan bonus accrual for employees dedicated to corporate operations. In addition, Income from our Business to Business and Retail and Wholesale Products as well as Corporate Expenses for the three and six months ended January 31, 2021 were adjusted for an immaterial correction of an error. See Note 1 of the Notes to the unaudited Condensed Consolidated Financial Statements.
| | | | | | | | | | | | | | | | | | | | | | | |
| For the Six Months Ended January 31, |
| Net Sales | | Income |
| 2022 | | 2021 | | 2022 | | 2021 |
| (in thousands) |
Business to Business Products Group | $ | 61,553 | | | $ | 53,805 | | | $ | 14,336 | | | $ | 14,713 | |
Retail and Wholesale Products Group | $ | 108,117 | | | 96,792 | | | $ | 1,000 | | | 6,728 | |
Net Sales | $ | 169,670 | | | $ | 150,597 | | | | | |
Corporate Expenses | | (12,973) | | | (12,020) | |
Income from Operations | | 2,363 | | | 9,421 | |
Total Other Income, Net | | 717 | | | 491 | |
Income before Income Taxes | | 3,080 | | | 9,912 | |
Income Tax Expense | | (524) | | | (1,675) | |
Net Income | | 2,556 | | | 8,237 | |
Net Loss Attributable to Noncontrolling Interest | | (31) | | | (46) | |
Net Income Attributable to Oil-Dri | | $ | 2,587 | | | $ | 8,283 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| For the Three Months Ended January 31, |
| Net Sales | | Income |
| 2022 | | 2021 | | 2022 | | 2021 |
| (in thousands) |
Business to Business Products Group | $ | 32,624 | | | $ | 26,283 | | | $ | 7,590 | | | $ | 7,113 | |
Retail and Wholesale Products Group | 54,586 | | | 48,217 | | | 926 | | | 3,178 | |
Net Sales | $ | 87,210 | | | $ | 74,500 | | | | | |
Corporate Expenses | | (6,598) | | | (6,047) | |
Income from Operations | | 1,918 | | | 4,244 | |
Total Other Income, Net | | 452 | | | 913 | |
Income before Income Taxes | | 2,370 | | | 5,157 | |
Income Tax Expense | | (409) | | | (869) | |
Net Income | | 1,961 | | | 4,288 | |
Net Loss Attributable to Noncontrolling Interest | | (41) | | | (11) | |
Net Income Attributable to Oil-Dri | | $ | 2,002 | | | $ | 4,299 | |
12. STOCK-BASED COMPENSATION
The Oil-Dri Corporation of America 2006 Long Term Incentive Plan, as amended (the “2006 Plan”), permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based and cash-based awards. Our employees and outside directors are eligible to receive grants under the 2006 Plan. The total number of shares of stock subject to grants under the 2006 Plan may not exceed 1,219,500. As of January 31, 2022, there were 260,356 shares available for future grants under this plan.
Restricted Stock
All of our non-vested restricted stock as of January 31, 2022 was issued under the 2006 Plan with vesting periods generally between one and five years. We determined the fair value of restricted stock as of the grant date. We recognize the related compensation expense over the period from the date of grant to the date the shares vest.
There were 32,000 and 18,000 restricted shares of Common Stock granted during the second quarter of fiscal years 2022 and 2021, respectively. Stock-based compensation expense was $817,000 and $506,000 for the second quarter of fiscal years 2022 and 2021, respectively. Stock-based compensation expense was $1,453,000 and $1,290,000 for the first six months of fiscal years 2022 and 2021, respectively.
A summary of restricted stock transactions is shown below:
| | | | | | | | | | | |
| Restricted Shares (in thousands) | | Weighted Average Grant Date Fair Value |
Non-vested restricted stock outstanding at July 31, 2021 | 370 | | | $ | 33.96 | |
Granted | 107 | | | $ | 34.56 | |
Vested | (56) | | | $ | 35.20 | |
Forfeitures | (14) | | | $ | 35.20 | |
Non-vested restricted stock outstanding at January 31, 2022 | 407 | | | $ | 33.90 | |
13. ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME
The following table summarizes the changes in accumulated other comprehensive (loss) income by component as of January 31, 2022 (in thousands):
| | | | | | | | | | | | | | | | | |
| Pension and Postretirement Health Benefits | | Cumulative Translation Adjustment | | Total Accumulated Other Comprehensive (Loss) Income |
Balance as of July 31, 2021 | $ | (4,428) | | | $ | 311 | | | $ | (4,117) | |
Other comprehensive loss before reclassifications, net of tax | — | | | (94) | | | (94) | |
Amounts reclassified from accumulated other comprehensive income, net of tax | 53 | | (a) | — | | | 53 | |
Net current-period other comprehensive income (loss), net of tax | 53 | | | (94) | | | (41) | |
Balance as of January 31, 2022 | $ | (4,375) | | | $ | 217 | | | $ | (4,158) | |
(a) Amount is net of tax expense of $16,620. Amount is included in the components of net periodic benefit cost for the pension and postretirement health plans. See Note 10 of the Notes to the unaudited Condensed Consolidated Financial Statements for further information.
14. RELATED PARTY TRANSACTIONS
One member of our Board of Directors (the “Board”) retired from the role of President and Chief Executive Officer of a customer of ours in September 2019 and is currently party to a post-employment agreement with the customer. Total net sales to that customer, including sales to subsidiaries of that customer, were $81,000 and $71,000 for the second quarter of fiscal years 2022 and 2021, respectively and were $156,000 and $181,000 for the first six months of fiscal years 2022 and 2021, respectively. Outstanding accounts receivable from that customer, and its subsidiaries, were $14,000 as of January 31, 2022 and $4,000 as of July 31, 2021.
One member of our Board is currently the President and Chief Executive Officer of a vendor of ours. Total payments to this vendor for fees and cost reimbursements were $350,000 and $109,000 for the second quarter of fiscal years 2022 and 2021, respectively and were $565,000 and $201,000 for the first six months of fiscal years 2022 and 2021, respectively. There were no outstanding accounts payable to that vendor as of January 31, 2022 or July 31, 2021.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read together with the financial statements and the related notes included herein and our Consolidated Financial Statements, accompanying notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended July 31, 2021. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from the results discussed in the forward-looking statements. Factors that might cause a difference include, but are not limited to, those discussed under “Forward-Looking Statements” and Item 1A, Risk Factors of this Quarterly Report on Form 10-Q for the quarter ended January 31, 2022 and of our Annual Report on Form 10-K for the fiscal year ended July 31, 2021.
OVERVIEW
We develop, mine, manufacture and market sorbent products principally produced from clay minerals and, to a lesser extent, other clay-like sorbent materials. Our principal products include agricultural and horticultural chemical carriers, animal health and nutrition products, bleaching clay and fluid purification aids, cat litter, industrial and automotive floor absorbents and sports field products. Our products are sold to two primary customer groups, including customers who resell our products as originally produced to the end consumer and those who use our products as part of their production process or use them as an ingredient in their final finished product. We have two reportable operating segments based on the different characteristics of our two primary customer groups: Retail and Wholesale Products Group and Business to Business Products Group, as described in Note 11 of the Notes to the unaudited Condensed Consolidated Financial Statements.
RESULTS OF OPERATIONS
OVERVIEW
In late 2019 and early 2020, COVID-19 was first reported and then declared a pandemic by the World Health Organization, and continues to have a worldwide impact. All of our facilities, with the exception of our subsidiary in China (which experienced certain disruptions in the first half of our fiscal year 2020 but subsequently resumed operations), have continued to operate as essential businesses during the course of the pandemic as permitted under exceptions in the applicable shelter-in-place mandates due to our inclusion in the Critical Manufacturing Sector as defined by the U.S. Department of Homeland Security and other functions defined as essential by government authorities. Our top priority has been, and continues to be, the safety and health of our employees, contractors, and customers. We have adhered, and continue to adhere, to guidance from the U.S. Centers for Disease Control and Prevention (“CDC”) and local health and governmental authorities with respect to social distancing, physical separation, and cleaning and sanitation programs at each of our facilities. We have not experienced any shut downs due to workforce absences or illnesses.
As further discussed below, our consolidated net sales increased in the second quarter and in the first six months of fiscal year 2022 compared to the second quarter and first six months of fiscal year 2021. Net sales of our industrial and sports products as well as most of our fluids purification products have mostly returned to pre-pandemic levels as many businesses and sports have re-opened and air travel has been increasing. Despite the overall increase in net sales, we have not experienced any significant issues collecting amounts due from customers to date. However, parts of our business continue to be negatively impacted by the pandemic. Net sales for our industrial granules in the United Kingdom have just recently started to increase in the second quarter of fiscal year 2022. While we have had an overall increase in net sales of our fluids purification products, not all regions have resumed travel to the same extent as prior to the pandemic. In addition, net sales of our animal health and nutrition products have been dampened due to COVID-19 and African swine fever in certain geographic areas. We have also experienced an increase in backlog due, in part, to supply chain disruptions and availability of labor amidst unprecedented demand for our products.
As discussed below in "Consolidated Results," gross profit has declined in both the second quarter and the first six months of fiscal year 2022 compared to the same periods in fiscal year 2021 related to rising costs and supply chain disruptions. We have faced longer lead times for some of our materials purchases, which have contributed to an increase in our backlog but have been able to avoid significant out of stock issues for most of our materials. Where possible, we have found other suppliers to meet the increase in customer demand for our products. In addition, the cost of repair parts has increased but this has not caused any significant disruption to our business. Further, we, along with some of our suppliers and toll processors, have experienced a shortage of production labor, which has been a contributing factor to our increase in backlog. We are closely monitoring the continuation, resurgence in certain areas, and effects of COVID-19 on all aspects of our business, including how it has impacted and may impact our suppliers and customers as well as the effects of the pandemic on economic conditions and the financial markets. In general, we have seen an increase in costs, particularly as it relates to commodities as the economy continues to
react to, and recover from, the pandemic and demand surpasses supply. In addition to rising commodity costs, several of our suppliers have started to pass along non-commodity price increases they have experienced in their own business. However, we have not experienced any significant interruptions, and we will continue to closely monitor our inventory levels to mitigate the risk of any potential supply interruptions or changes in customer demand. It is possible that significant disruptions could occur if the pandemic and other factors such as labor shortages, ongoing geopolitical tensions, and other strains on the supply chain continue to put pressure on production, transportation, and shipping as a result of an imbalance of supply and demand or if there are continued increases in costs that we are unable to recover. The impacts of COVID-19 and related economic conditions on our future results are uncertain at this time. The scope, duration, and magnitude of the direct and indirect effects of COVID-19 continue to evolve (and in many cases, rapidly) in ways that are difficult or impossible to anticipate. In addition, although COVID-19 has not materially impacted our net sales to date, it remains uncertain whether and how consumers will modify their purchasing habits in response to the ongoing COVID-19 pandemic and/or the lifting or relaxing of mandates as the pandemic abates in certain areas and government restrictions are reduced and/or reimposed. As a result, our results to date may not be indicative of the impact that COVID-19 may have on our results for the remainder of fiscal year 2022.
The impacts of COVID-19 to our specific operating segments are discussed below.
SIX MONTHS ENDED JANUARY 31, 2022 COMPARED TO
SIX MONTHS ENDED JANUARY 31, 2021
CONSOLIDATED RESULTS
Consolidated net sales for the six months ended January 31, 2022 were $169,670,000, a 13% increase compared to net sales of $150,597,000 for the six months ended January 31, 2021. Net sales increased for both our Retail and Wholesale Products Group and Business to Business Products Group primarily due to an increase in sales volume and somewhat due to higher prices instituted to compensate for rising costs. The increase in demand for our products during the first six months of fiscal year 2022 has led to an increase in our backlog of orders driven by late customer pick-ups and our own constraints related to production, capacity and transportation. We have hired additional manufacturing personnel, expanded our production shifts and increased production equipment to aid in the resolution of these constraints in the coming months as well as increased our use of alternate modes of transportation. We continue to analyze our constraints and implement strategies to meet the increase in customer demand. Segment results are discussed further below.
Consolidated gross profit for the first six months of fiscal year 2022 was $29,404,000, or 17% of net sales, compared to $35,469,000, or 24%, of net sales, for the first six months of fiscal year 2021. Higher freight, packaging, natural gas, and non-fuel manufacturing costs per ton drove the decrease in gross profit. We continue to experience high freight costs both domestically and with respect to ocean freight. Domestic freight costs per ton, excluding the freight we no longer charge to a significant customer who now picks up its own purchases, increased approximately 35% in the first six months of fiscal year 2022 compared to the same period of fiscal year 2021. The increase relates to, in part, higher transportation rates due to a national driver shortage and tight trucking capacity. The continued increase in cost of diesel fuel has also contributed to the higher transportation rates. In addition, our overall freight costs can vary between periods depending on the mix of products sold and the geographic distribution of our customers. Packaging costs per ton for the first six months of fiscal year 2022 were approximately 37% higher compared to the first six months of fiscal year 2021 due to higher commodity costs, particularly as it relates to resin. Many of our contracts for packaging purchases are subject to periodic price adjustments, which trail changes in underlying commodity prices. The cost of natural gas per ton used to operate kilns that dry our clay was 93% higher in the first six months of fiscal year 2022 compared to the first six months of fiscal year 2021 due to higher natural gas prices, which are being driven by demand surpassing available supply. Non-fuel manufacturing costs per ton also increased during the first six months of fiscal year 2022 compared to fiscal year 2021 by 14%. The increase in non-fuel manufacturing costs relate to higher repairs, labor costs, and costs of purchased materials. In addition to the above, during the first six months of fiscal year 2022, several suppliers started to pass along non-commodity price increases related to cost increases experienced in their own businesses and we expect such increases to persist. While we have faced higher costs due to the reasons mentioned above, we continue to strive to restore our historical margins utilizing various strategies including reducing costs where possible, increasing sales volume, and implementing price increases.
Total selling, general and administrative (“SG&A”) expenses of $27,041,000 for the first six months of fiscal year 2022 were higher by $993,000, or 4%, compared to $26,048,000 for the first six months of fiscal year 2021. SG&A expenses for the operating segments were essentially flat for the, first six months of fiscal year 2022 compared to the same period in the prior fiscal year and unallocated corporate expenses were higher by $953,000, or 8%. The discussion of the segments' operating incomes below describes the changes in SG&A expenses that were allocated to the operating segments. The increase in unallocated corporate expenses were driven by higher professional fees related to costs for various outside services related to growing business needs and strategic initiatives.
Other income of $717,000 for the first six months of fiscal year 2022 was higher than the same period in fiscal year 2021 by $226,000 and included less periodic benefit costs related to our pension plan and insurance recoveries related to our property, plant and equipment partially offset by higher interest expense and exchange rate losses.
Consolidated net income before taxes for the first six months of fiscal year 2022 was $3,080,000 compared to net income before taxes of $9,912,000 for the first six months of fiscal year 2021. Results for the first six months of fiscal year 2022 were driven by the factors discussed above.
Tax expense for the first six months of fiscal year 2022 was $524,000 compared to $1,675,000 for the first six months of fiscal year 2021, which resulted in an effective tax rate of 17% in both periods. We used an estimated annual effective tax rate (“ETR”) in determining our provision for income taxes, which is based on expected annual taxable income and the assessment of various tax deductions, including depletion.
BUSINESS TO BUSINESS PRODUCTS GROUP
Net sales of the Business to Business Products Group for the first six months of fiscal year 2022 increased compared to the first six months of fiscal year 2021 for all our products. Net sales were $61,553,000 for the first six months of fiscal year 2022, an increase of $7,748,000, or 14%, from net sales of $53,805,000 for the first six months of fiscal year 2021. Net sales of our fluids purification products increased approximately $4,134,000, or 16%, compared to the first six months of the prior fiscal year. We experienced sales improvement primarily in Latin America, North America and Asia. The increases in net sales to these countries were partially offset by lower net sales to Europe. The increase in net sales occurred for a variety of reasons, including new customer wins, increased sales to existing customers, increase in air travel, price increases that were instituted to offset rising costs, and in some cases, timing of net sales. Net sales of our Ultra-Clear clay products rebounded as global air travel increased compared to the same period last year. Net sales of bleaching clay to Europe decreased primarily as a function of timing and ocean freight shipping delays. Similar to our Retail and Wholesale Products Group cat litter business, our co-packaged coarse cat litter business experienced a significant increase of 23% in net sales during the first six months of fiscal year 2022 compared to fiscal year 2021 primarily due to price increases and to some extent, an increase in volume. Net sales of our agricultural and horticultural chemical carrier products increased approximately $1,486,000, or 12%, for the first six months of fiscal year 2022 compared to the same period in fiscal year 2021 as a result of continued strong demand for these products as well as price increases. Net sales of our animal health and nutrition products increased $413,000, or 5%, during the first six months of fiscal year 2022 compared to the first six months of the prior year. The increase in net sales relates to several new customers, a new product line in North America, and in general, timing of when sales occur. Despite the overall increase in net sales, the African swine fever and low pork prices are still affecting the swine market and ultimately, the net sales of our feed additives in some countries. The swine population has been reduced, and demand and consumption are down, thereby causing a decrease in our net sales in some regions, mostly in China. Ocean freight delays also continue to negatively impact our business. See “Foreign Operations” below for a discussion of net sales for our foreign operations that sell our animal health and nutrition products.
SG&A expenses for the Business to Business Products Group increased approximately 19% or $1,081,000 for the first six months of fiscal year 2022 compared to the same period of the prior fiscal year. We continued to invest in our animal health business which resulted in higher costs due to increased headcount of sales and leadership personnel, increased travel costs, and increased marketing efforts associated with our animal feed additives.
The Business to Business Products Group’s operating income for the first six months of fiscal year 2022 was $14,336,000, a decrease of $377,000, or 3%, from operating income of $14,713,000 for the first six months of fiscal year 2021. The decrease in operating income was driven by higher freight, packaging, natural gas, and non-fuel manufacturing costs per ton as discussed in “Consolidated Results” above as well as higher SG&A expenses.
RETAIL AND WHOLESALE PRODUCTS GROUP
Net sales of the Retail and Wholesale Products Group for the first six months of fiscal year 2022 were $108,117,000, an increase of $11,325,000, or 12%, from net sales of $96,792,000 for the first six months of fiscal year 2021 driven by higher net sales of both our cat litter and industrial and sports products. Total cat litter net sales were approximately $7,262,000, or 9%, higher compared to the first six months of the prior fiscal year primarily due to increased sales volume and somewhat due to price increases in response to rising costs. Net sales of branded scoopable litter, private label lightweight and heavyweight litter, and accessories (liners) increased in the first six months of fiscal year 2022 as we gained business from new customers and existing customers either sold certain of our products for the first time or increased the volume of their purchases from us. E-commerce sales were also higher during the first six months of fiscal year 2022 compared to fiscal year 2021. The impact of COVID-19 on increased pet adoption continues to boost sales as well as the overall macro trend of increased spending on pets. In addition, cat litter net sales increased despite revising our shipping terms with one of our significant customers in the fourth quarter of fiscal year 2021 to provide that freight charges are the responsibility of such customer and no longer included in the
prices charged. Cat litter net sales by our subsidiary in Canada further contributed to the net sales increase, as discussed in “Foreign Operations” below. Also included in the Retail and Wholesale Products Group's results were increased net sales of our industrial and sports products compared to the first six months of fiscal year 2021. Net sales of our industrial and sports products increased approximately $3,968,000, or 28%, compared to the first six months of fiscal year 2021, due to both an increase in volume due to the re-opening of businesses and sports fields as well as an increase in selling price per ton as we continue to respond to rising costs.
SG&A expenses for the Retail and Wholesale Products Group were lower by approximately $1,074,000, or 12%, during the first six months of fiscal year 2022 compared to the first six months of fiscal year 2021 primarily due to lower advertising costs partially offset by compliance penalties caused by supply chain disruptions, travel expense and personnel costs. We anticipate total advertising expense in fiscal year 2022 will be lower compared to fiscal year 2021.
The Retail and Wholesale Products Group's operating income for the first six months of fiscal year 2022 was $1,000,000, a decrease of $5,728,000, or 85%, from operating income of $6,728,000 for the first six months of fiscal year 2021. The decrease in operating income was driven by higher freight, packaging, natural gas and non-fuel costs as discussed in “Consolidated Results” above which outpaced the increase in net sales.
FOREIGN OPERATIONS
Foreign operations include our subsidiaries in Canada and the United Kingdom, which are reported in the Retail and Wholesale Products Group, and our subsidiaries in China, Mexico and Indonesia, which are reported in the Business to Business Products Group. Net sales by our foreign subsidiaries during the first six months of fiscal year 2022 were $9,626,000, an increase of $787,000, or 9%, compared to net sales of $8,839,000 during the first six months of fiscal year 2021. Total net sales of our subsidiary in Canada during the first six months of fiscal year 2022 increased by $1,226,000, or 27%, compared to the same period in fiscal year 2021 driven by higher cat litter net sales. The increase was mainly driven by a key customer carrying three of our products for the first time as well as price increases instituted in response to rising costs. Net sales of our industrial absorbent granules were flat in the first six months of fiscal year 2022 compared to the first six months of fiscal year 2021. Net sales of our subsidiary in the United Kingdom in the first six months of fiscal year 2022 increased by $95,000, or 10%, compared to net sales of the first six months of fiscal year 2021. The increase related to timing of net sales and partly due to demand starting to slowly return post pandemic. Net sales of our subsidiary in Mexico decreased during the first six months of fiscal year 2022 compared to the same period of fiscal year 2021 by $420,000, or 29%, as the first six months of fiscal year 2021 included net sales of products that are no longer part of our business strategy. Net sales of our subsidiary in China decreased $129,000, or 7%, during the first six months of fiscal year 2022 compared to the first six months of fiscal year 2021. The decrease relates primarily to the impact of the African swine fever, low pork prices, as well as timing of net sales due to ocean freight delays and because some customers made purchases in the prior fiscal year ahead of effective price increases. Net sales by our foreign subsidiaries represented 6% of our consolidated net sales during the first quarter of fiscal years 2022 and 2021.
Our foreign subsidiaries reported a net loss of $812,000 for the first six months of fiscal year 2022, compared to a net loss of $42,000 for the first six months of fiscal year 2021. The net loss in the first six months of fiscal year 2022 was primarily driven by lower net sales for our subsidiary in Mexico, higher cost of sales and higher SG&A expenses by our subsidiary in China due to increased sales personnel and marketing of our animal feed additives as we continue to invest in our animal health and nutrition products.
Identifiable assets of our foreign subsidiaries as of January 31, 2022 were $12,174,000, compared to $12,572,000 as of July 31, 2021.
THREE MONTHS ENDED JANUARY 31, 2022 COMPARED TO
THREE MONTHS ENDED JANUARY 31, 2021
CONSOLIDATED RESULTS
Consolidated net sales for the three months ended January 31, 2022 were $87,210,000, a 17% increase compared to net sales of $74,500,000 for the three months ended January 31, 2021. Net sales increased for both our Retail and Wholesale Products Group and Business to Business Products Group primarily due to an increase in sales volume and somewhat due to higher prices instituted to compensate for rising costs. The increase in demand for our products during the second quarter of fiscal year 2022 has continued to increase the backlog that arose in the first quarter of fiscal year 2022. See discussion above in “Results from Operations - Six Months Ended January 31, 2022 compared to Six Months ended January 31, 2021” for more detail on backlog. Segment results are discussed below.
Consolidated gross profit for the three months ended January 31, 2022 was $15,586,000, or 18% of net sales, compared to
$16,689,000, or 22%, of net sales, for the three months ended January 31, 2021. Higher freight, packaging, natural gas, and non-fuel manufacturing costs per ton drove the decrease in gross profit. We continue to experience high freight costs both domestically and with respect to ocean freight. Domestic freight costs per ton, excluding the freight we no longer charge to a significant customer who now picks up its own purchases, increased approximately 31% in the second quarter of fiscal year 2022 compared to the same period of fiscal year 2021. The increase relates, in part, to higher transportation rates due to a national driver shortage and tight trucking capacity. The continued increase in cost of diesel fuel has also contributed to the higher transportation rates. Our overall freight costs can also vary between periods depending on the mix of products sold and the geographic distribution of our customers. Packaging costs per ton for the second quarter of fiscal year 2022 were approximately 30% higher compared to the second quarter of fiscal year 2021 due to higher commodity costs, particularly as it relates to resin. Many of our contracts for packaging purchases are subject to periodic price adjustments, which trail changes in underlying commodity prices. The cost of natural gas per ton used to operate kilns that dry our clay was 90% higher in the second quarter of fiscal year 2022 compared to the second quarter of fiscal year 2021 due to higher natural gas prices which are being driven by demand surpassing available supply. Non-fuel manufacturing costs per ton also increased during the second quarter of fiscal year 2022 compared to fiscal year 2021 by 9%. The increase in non-fuel manufacturing costs relate to higher repairs, labor costs and costs of purchased materials. In addition to the above, during the second quarter of fiscal year 2022, several suppliers started to pass along non-commodity price increases related to cost increases experienced in their own businesses and we expect such increases to persist. While we have faced higher costs due to the reasons mentioned above, we continue to strive to restore our historical margins utilizing various strategies including reducing costs where possible, increasing sales volume and implementing price increases.
Total SG&A expenses of $13,668,000 for the second quarter of fiscal year 2022 were higher by $1,223,000, or 10%, compared to $12,445,000 for the second quarter of fiscal year 2021. SG&A expenses for both the operating segments and unallocated corporate expenses contributed to the increase. The discussion below describes the SG&A expenses allocated to the operating segments. The increase in unallocated corporate expenses were driven by higher professional fees related to costs for various outside services related to growing business needs and strategic initiatives.
Other income of $452,000 for the second quarter of fiscal year 2022 was lower than the same period in fiscal year 2021 by $461,000 and included higher interest expense and exchange rate losses partially offset by insurance recoveries related to our property, plant and equipment.
Consolidated net income before taxes for the second quarter of fiscal year 2022 was $2,370,000, compared to net income before taxes of $5,157,000 for the second quarter of fiscal year 2021. Results for the second quarter of fiscal year 2022 were driven by the factors described above.
Tax expense for the second quarter of fiscal year 2022 was $409,000 compared to tax expense $869,000 for the second quarter of fiscal year 2021, which resulted in an effective tax rate of 17% in both periods. We used an estimated annual effective tax rate in determining our provision for income taxes, which is based on expected annual taxable income and the assessment of various tax deductions, including depletion.
BUSINESS TO BUSINESS PRODUCTS GROUP
Net sales of the Business to Business Products Group for the second quarter of fiscal year 2022 increased compared to the second quarter of fiscal year 2021 for all our products. Net sales were $32,624,000, an increase of $6,341,000, or 24%, from net sales of $26,283,000 for the second quarter of fiscal year 2021. Net sales of our fluids purification products increased approximately $2,270,000, or 18%, in the second quarter of fiscal year 2022 compared to same period in fiscal year 2021. The increase in net sales occurred for a variety of reasons, including new customer wins, increased sales to existing customers, increase in air travel, price increases that were instituted to offset rising costs and in some cases, timing of net sales. Net sales of our Ultra-Clear products rebounded as global air travel increased compared to the same period last year. Net sales of our agricultural and horticultural chemical carrier products increased approximately $2,265,000, or 45%, in the second quarter of fiscal year 2022 compared to the same period in fiscal year 2021 driven by both volume and to some degree, price increases. The increase in volume is attributable to continued strong demand for our products as well as a shift in timing of net sales from the first quarter to the second quarter of fiscal year 2022 as several of our customer delayed their orders due to their own supply chain issues. In addition, one of our customers had partially shut down in the second quarter of fiscal year 2021 which reduced our net sales and then later resumed operations. Similar to our Retail and Wholesale Products Group cat litter business, our co-packaged coarse cat litter business experienced a significant increase of $955,000, or 26%, in net sales during the second quarter of fiscal year 2022, compared to the same quarter in fiscal year 2021, primarily due to price increases and to some extent, an increase in volume. Net sales of our animal health and nutrition products increased approximately $851,000, or 18%, in the second quarter of fiscal 2022 compared to the second quarter of fiscal year 2021. The increase in net sales relates to several new customers, a new product line in North America, and in general, timing of when net sales occur. Despite the overall increase in net sales, ocean freight delays continue to negatively impact our business. African swine fever and low pork prices are still affecting the swine market and ultimately, the net sales of our feed additives in some countries. The swine population has been reduced, and demand and consumption are down, thereby causing a decrease in our net sales in some regions, mostly in China. However, net sales from our subsidiary in China increased during the second quarter of fiscal year 2022 compared to
fiscal year 2021 primarily due to a new customer. See “Foreign Operations” below for a discussion of net sales for our foreign operations that sell our animal health and nutrition products.
SG&A expenses for the Business to Business Products Group increased approximately $569,000, or 19%, in the second quarter of fiscal year 2022 compared to the second quarter of fiscal year 2021. We continued to invest in our animal health business which resulted in higher costs due to increased headcount of sales and leadership personnel, increased travel costs, and increased marketing efforts associated with our animal feed additives partially offset by lower bad debt expenses.
The Business to Business Products Group’s operating income for the second quarter of fiscal year 2022 was $7,590,000, an increase of $477,000, or 7%, from operating income of $7,113,000 in the second quarter of fiscal year 2021. The increase in operating income was driven by the higher sales partially offset by higher SG&A expenses and an increase in freight, packaging, materials, natural gas, and non-fuel manufacturing costs discussed in “Consolidated Results” above.
RETAIL AND WHOLESALE PRODUCTS GROUP
Net sales of the Retail and Wholesale Products Group for the second quarter of fiscal year 2022 were $54,586,000, an increase of $6,369,000, or 13%, from net sales of $48,217,000 for the second quarter of fiscal year 2021 driven by net sales of both our cat litter and industrial and sports products. Total cat litter net sales were approximately $4,161,000, or 10%, higher in the second quarter of fiscal year 2022 compared to the same period in fiscal year 2021 due to increased sales volume and somewhat due to price increases in response to rising costs. Net sales of branded scoopable litter, private label lightweight and heavyweight litter increased in the second quarter of fiscal year 2022 as existing customers either sold certain of our products for the first time or increased the volume of their purchases from us. The impact of COVID-19 on increased pet adoption continues to boost sales as well as the overall macro trend of increased spending on pets. In addition, cat litter net sales increased despite revising our shipping terms with one of our significant customers in the fourth quarter of fiscal year 2021 to provide that freight charges are the responsibility of such customer and no longer included in the prices charged. In addition, net sales of cat litter by our subsidiary in Canada continue to increase as further discussed in “Foreign Operations” below. E-commerce sales were flat during the second quarter of fiscal year 2022 compared to the same period in fiscal year 2021. Also included in the Retail and Wholesale Products Group's results were increased net sales of our industrial and sports products compared to the second quarter of fiscal year 2021. Net sales of our industrial and sports products increased approximately $2,110,000, or 31%, in the second quarter of fiscal year 2022 compared to the second quarter of fiscal year 2021, due to both an increase in volume due to the re-opening of businesses and sports fields as well as an increase in selling price per ton in response to rising costs.
SG&A expenses for the Retail and Wholesale Products Group were lower in the second quarter of fiscal year 2022 than in fiscal year 2021 by 1%, or $41,000, primarily due to lower advertising costs partially offset by compliance penalties caused by supply chain disruptions, travel expense and personnel costs.
For the second quarter of fiscal year 2022, the Retail and Wholesale Products Group reported operating income of $926,000, a decrease of $2,252,000, compared to operating income of $3,178,000 for the second quarter of fiscal year 2021. The decrease in operating income was driven by higher freight, packaging, natural gas, and non-fuel manufacturing costs described above in “Consolidated Results” which outpaced higher net sales.
FOREIGN OPERATIONS
Foreign operations include our subsidiaries in Canada and the United Kingdom, which are reported in the Retail and Wholesale Products Group, and our subsidiaries in China, Mexico and Indonesia, which are reported in the Business to Business Products Group. Net sales by our foreign subsidiaries during the second quarter of fiscal year 2022 were $5,283,000, a 12% increase compared to net sales of $4,703,000 in the second quarter of fiscal year 2021. All of our foreign operations, with the exception of our subsidiary in Mexico, experienced an increase in net sales during the second quarter of fiscal year 2022 compared to fiscal year 2021. Total net sales of our subsidiary in Canada during the second quarter of fiscal year 2022 increased by $566,000, or 24%, compared to the same period in fiscal year 2021 driven by cat litter net sales. Cat litter net sales for our subsidiary in Canada increased by approximately $499,000, or 27%, in the second quarter of fiscal year 2022 compared to the same period of fiscal year 2021 due to increased sales to existing customers, a key customer carrying three of our products they had not previously purchased and, to some extent, price increases to keep pace with rising costs. Moreover, the impact of COVID-19 on increased pet adoption continues to boost cat litter net sales as well as the overall macro trend of increased spending on pets. In addition to increased net sales of cat litter, net sales of our industrial absorbent granules in Canada increased by approximately $67,000, or 12%, during the second quarter of fiscal year 2022 compared to the same period in fiscal year 2021. Net sales of our absorbent granules by our subsidiary in the United Kingdom increased by $97,000 during the second quarter of fiscal year 2022 compared to the same period in fiscal year 2021. This increase related partly due to timing of net sales and partly due to demand starting to slowly return in the United Kingdom. Net sales of our animal health and nutrition
products by our subsidiary in China increased moderately in the second quarter of fiscal year 2022 compared to the same period in fiscal year 2021 by $130,000, or 12%. The increase in net sales related primarily to a new customer. Net sales by our subsidiary in Mexico decreased $298,000, or 39%, in the second quarter of fiscal year 2022 compared to the same period in fiscal year 2021 as the second quarter of fiscal year 2021 included net sales of products that are no longer part of our business strategy. Our foreign subsidiaries' net sales represented approximately 6% of consolidated net sales during the second quarters of fiscal years 2022 and 2021.
Our foreign subsidiaries reported a net loss of $477,000 for the second quarter of fiscal year 2022 compared to net income of $170,000 for the second quarter of fiscal year 2021. The net loss in the second quarter of fiscal year 2022 was primarily driven by lower net sales of our subsidiary in Mexico, higher cost of sales, and higher SG&A expenses incurred by our subsidiary in China due to increased sales personnel and marketing of our animal feed additives as we continue to invest in our animal health and nutrition products.
LIQUIDITY AND CAPITAL RESOURCES
Our principal capital requirements include: funding working capital needs; purchasing and upgrading equipment, facilities (including significant renovations at one of our plants), information systems, and real estate; supporting new product development; investing in infrastructure; repurchasing stock; paying dividends; making pension contributions; and, from time to time, business acquisitions. During the first six months of fiscal year 2022, we principally funded these requirements using cash from current operations as well as cash generated in the second quarter of fiscal year 2022 from borrowings.
We currently anticipate cash flows from operations and our available sources of liquidity will be sufficient to meet our cash requirements. In addition, we are actively monitoring the timing and collection of our accounts receivable. Given the dynamic nature of COVID-19 and its effects, we will continue to assess our liquidity needs and to actively manage our spending.
The following table sets forth certain elements of our unaudited Condensed Consolidated Statements of Cash Flows (in thousands):
| | | | | | | | | | | |
| For the Six Months Ended January 31, |
| 2022 | | 2021 |
Net cash provided by operating activities | $ | 61 | | | $ | 3,085 | |
Net cash used in investing activities | (10,574) | | | (7,595) | |
Net cash provided by (used in) financing activities | 14,957 | | | (5,795) | |
Effect of exchange rate changes on cash and cash equivalents | (26) | | | 123 | |
Net increase (decrease) in cash and cash equivalents | $ | 4,418 | | | $ | (10,182) | |
Net cash provided by operating activities
In addition to net income, as adjusted for depreciation and amortization and other non-cash operating activities, the primary sources and uses of operating cash flows for the first six months of fiscal years 2022 and 2021 were as follows:
Accounts receivable, less allowance for doubtful accounts, increased $5,082,000 in the first six months of fiscal year 2022 compared to an increase of $3,836,000 in the first six months of fiscal year 2021. The change in accounts receivable was higher in fiscal year 2022 than fiscal year 2021 because net sales increased significantly in the first six months of fiscal year 2022, thereby driving accounts receivable higher. In addition, the variation in accounts receivable balances reflect differences in the level and timing of collections as well as the payment terms provided to various customers.
Inventory increased $6,236,000 in the first six months of fiscal year 2022 compared to a decrease of $412,000 in the first six months of fiscal year 2021. While inventory increased in both periods due to rising costs, costs rose much more significantly in the first six months of fiscal year 2022. In addition, during the first six months of fiscal year 2022 we increased our inventory levels to accommodate increased demand and thwart potential supply chain disruptions. The decrease in inventory in the first six months of fiscal year 2021 was due to increased demand which offset the higher packaging costs.
Prepaid expenses decreased $846,000 in the first six months of fiscal year 2022 due to lower prepaid advertising costs and insurance somewhat offset by higher prepaid repairs. Prepaid expenses increased $760,000 in the first six months of fiscal year 2021 driven primarily by prepayment of income taxes. This increase in fiscal year 2021 was offset by lower prepaid advertising costs and insurance.
Other assets decreased $634,000 in the first six months of fiscal year 2022 compared to an increase of $266,000 in the first six months of fiscal year 2021. The decrease in other assets in the first six months of fiscal year 2022 related to capitalized pre-production costs being transferred to property, plant and equipment as the mines are now in production, partially offset by an increase in long-term royalties. The increase in other assets in the first six months of fiscal year 2021 related primarily to an increase in capitalized pre-production mining costs offset by amortization of our operating lease right-of-use lease assets.
Accounts payable increased $1,326,000 in the first six months of fiscal year 2022 compared to a decrease of $3,901,000 in the first six months of fiscal year 2021. Higher trade payables drove the increase in accounts payable in the first six months of fiscal year 2022. Lower trade payables drove the decrease in accounts payable in the first six months of fiscal year 2021 as well as income taxes payable being in a prepaid position versus a payable position at the end of the second quarter of fiscal year 2021. Trade and freight payables vary in both periods due to the timing of payments, fluctuations in the cost of goods and services we purchased, production volume levels and vendor payment terms.
Accrued expenses decreased $1,595,000 in the first six months of fiscal year 2022 compared to a decrease of $5,201,000 in the first six months of fiscal year 2021. The payout of the prior fiscal year's discretionary incentive bonus reduced accrued expenses in both fiscal years, but to a greater extent in fiscal year 2021 as the accrual was higher in the prior fiscal year. In addition, the timing of real estate tax payments also reduced accrued expenses in the first six months of fiscal year 2022. The decrease in accrued bonus and real estate taxes was partly offset by higher accrued utilities due to the rising cost of natural gas, higher accrued advertising due to the timing of our advertising programs, and additional accrued capital projects. In addition, accrued plant expenses can also fluctuate due to timing of payments, changes in the cost of goods and services we purchase, production volume levels and vendor payment terms. Accrued expenses decreased $5,201,000 in the first six months of fiscal year 2021 due to before-mentioned payout of discretionary incentive bonus, decreased accrued advertising and real estate taxes partially offset by the reclassification of the current portion of the deferred employer payroll taxes under the CARES Act which was paid at the end of calendar year 2021 as further described in Note 1 of the Notes to the unaudited Condensed Financial Statements and an increase in accrued freight.
Net cash used in investing activities
Cash used in investing activities of $10,574,000 in the first six months of fiscal year 2022 were higher compared to cash used in investing activities of $7,595,000 in the first six months of fiscal year 2021 driven by capital expenditures. During the first six months of fiscal year 2022 we expanded our plant equipment and improved our facilities to support increased demand for our products as well as made improvements to our IT network.
Net cash used in financing activities
Cash provided by financing activities of $14,957,000 in the first six months of fiscal year 2022 was higher than cash used in financing activities of $5,795,000 in the first six months of fiscal year 2021. The first six months of fiscal year 2022 included the issuance of $25,000,000 of notes payable offset by higher repurchases of stock than in the first six months of fiscal year 2021.
Other
Total cash and investment balances held by our foreign subsidiaries of $2,053,000 as of January 31, 2022 were lower than the January 31, 2021 balances of $3,411,000. See further discussion in “Foreign Operations” above.
On January 31, 2019, we signed a fifth amendment to our credit agreement with BMO Harris Bank N.A. (“BMO Harris”), which expires on January 31, 2024. The agreement provides for a $45,000,000 unsecured revolving credit agreement and a maximum of $10,000,000 for letters of credit. The agreement terms also state that we may select a variable interest rate based on either the BMO Harris prime rate or a LIBOR-based rate, plus a margin that varies depending on our debt to earnings ratio, or a fixed rate as agreed between us and BMO Harris. As of January 31, 2022, the variable rates would have been 3.50% for the BMO Harris prime-based rate or 1.56% for the three-month LIBOR-based rate. The credit agreement contains restrictive covenants that, among other things and under various conditions, limit our ability to incur additional indebtedness or to dispose of assets. The agreement also requires us to maintain a minimum fixed coverage ratio and a minimum consolidated net worth. As of January 31, 2022 and 2021, we were in compliance with the covenants. There were no borrowings during the first six months of either fiscal year 2021 or 2022.
On May 15, 2020, we entered into a debt instrument pursuant to which, among other things, we issued $10,000,000 in aggregate principal amount of our 3.95% Series B Senior Notes due May 15, 2030 and entered into an amended note agreement that provides the Company with the ability to request, from time to time until May 15, 2023 (or such earlier date as provided for in the agreement), additional senior unsecured notes of the Company in an aggregate principal amount of up to $75,000,000
minus the aggregate principal amount of the notes then outstanding and the additional notes that have been accepted for purchase. The issuance of such additional notes is at the discretion of the noteholders and purchasers and on an uncommitted basis. Pursuant to the amended note agreement, on December 16, 2021, the Company issued $25,000,000 in aggregate principal amount of its 3.25% Series C Senior Notes due December 16, 2031. As of January 31, 2021 outstanding notes payable were $33,778,000, net of $222,000 of unamortized debt issuance costs.
As of January 31, 2022, we had remaining authority to repurchase 637,109 shares of Common Stock and 273,100 shares of Class B Stock under a repurchase plan approved by our Board of Directors (the “Board”). Repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing, number and manner of share repurchases will be determined by our management pursuant to the repurchase plan approved by our Board.
We believe that cash flow from operations, availability under our revolving credit facility, current cash and investment balances and our ability to obtain other financing, if necessary, will provide adequate cash funds for foreseeable working capital needs, capital expenditures at existing facilities, deferred compensation payouts, dividend payments and debt service obligations for at least the next 12 months. We expect capital expenditures in fiscal year 2022 to be greater than in fiscal year 2021, including capital expenditures to renovate one of our plants, estimated to be approximately $6,500,000. We do not believe that these increased capital expenditures will dramatically impact our cash position; however our cash requirements are subject to change as business conditions warrant and opportunities arise. Our anticipated advertising expense for fiscal year 2022 is expected to be lower compared to fiscal year 2021. Adjustments to advertising spending for the remainder of the fiscal year may occur due to any upcoming volatility in the economic environment.
We continually evaluate our liquidity position and anticipated cash needs, as well as the financing options available to obtain additional cash reserves. Our ability to fund operations, to make planned capital expenditures, to make scheduled debt payments, to contribute to our pension plan and to remain in compliance with all financial covenants under debt agreements, including, but not limited to, the current credit agreement, depends on our future operating performance, which, in turn, is subject to prevailing economic conditions and to financial, business and other factors. The timing and size of any new business ventures or acquisitions that we complete may also impact our cash requirements.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
This discussion and analysis of financial condition and results of operations is based on our unaudited Condensed Consolidated Financial Statements, which have been prepared in accordance with U.S. GAAP for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. The preparation of these financial statements requires the use of estimates and assumptions related to the reporting of assets, liabilities, revenues, expenses and related disclosures. In preparing these financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. Estimates and assumptions are revised periodically. Actual results could differ from these estimates. See the information concerning our critical accounting policies included under “Management’s Discussion of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended July 31, 2021.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Management conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. The controls evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”). Based upon the controls evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the SEC, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
We have not experienced any material impact to our internal controls over financial reporting despite the fact that many of our employees are working remotely due to COVID-19. We are continually monitoring and assessing the effects of COVID-19 on our internal controls to minimize the impact to their design and operating effectiveness.
There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the fiscal quarter ended January 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Our management, including the CEO and CFO, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
PART II – OTHER INFORMATION
Items 1, 3 and 5 of this Part II are either inapplicable or are answered in the negative and are omitted pursuant to the instructions to Part II.
ITEM 1A. RISK FACTORS
The Company's operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended July 31, 2021. Except as set forth below, there have been no material changes to our risk factors since the Company's Annual Report on Form 10-K for the year ended July 31, 2021.
Price or trade concessions, the failure to make them to retain customers, or other price reductions could adversely affect our sales and profitability.
The products we sell are subject to significant price competition and the prices may fluctuate for a variety of reasons. From time to time, we may need to reduce the prices for some of our products to respond to competitive and customer pressures and to maintain market share. These pressures are often exacerbated during an economic downturn. Additionally, we have, from time to time, experienced customer-driven price deductions on our products as a result of delayed shipments of products. Any reduction in prices to respond to these pressures would reduce our profit margins. In addition, if our sales volumes fail to grow sufficiently to offset any reduction in margins, our results of operations would suffer. Because of the competitive environment facing many of our customers, particularly our high-volume mass merchandiser customers, these customers have increasingly sought to obtain price reductions, deductions, specialized packaging or other concessions from product suppliers. These business demands may relate to inventory practices, logistics or other aspects of the customer-supplier relationship. To the extent we provide these concessions, our profit margins are reduced. Further, if we are unable to maintain terms that are acceptable to our customers, these customers could reduce purchases of our products and increase purchases of products from our competitors, which would harm our sales and profitability.
Increases in energy, commodity, transportation and other costs would increase our operating costs, and we may be unable to pass all these increases on to our customers in the form of higher prices and surcharges.
If our energy, commodity and transportation costs increase disproportionately to our net sales, our earnings could be significantly reduced. Increases in our operating costs may reduce our profitability if we are unable to pass all the increases on to our customers through price increases or surcharges. Sustained price increases, surcharges or price inflation (or inflation pressure generally), in turn, may lead to declines in volume, and while we seek to project tradeoffs between price increases, surcharges and inflation, on the one hand, and volume, on the other, there can be no assurance that our projections will prove to be accurate. In particular, as a result of the COVID-19 pandemic and increased demand in trucking in certain areas of the United States following the reopening of state economies as well as increased shipping demand globally, which has impacted overseas vessel deliveries, the Company has experienced significant increases in transportation costs, decreases in the availability of shipping, and other global supply chain complexities and could experience delays in customer shipments and increased customer deductions for late shipments. Such increases in transportation costs may be further exacerbated by volatile global oil and gas markets. Given the varying level of re-openings and the continued spread of the pandemic globally (and
uncertainty regarding how areas will respond to a continued or renewed spread), it is possible that significant disruptions could occur if the pandemic continues to put pressure on transportation and shipping as a result of an imbalance of supply and demand or if there are continued increases in costs that we are unable to recover. The duration and magnitude of the increased transportation costs cannot be predicted at this time and there can be no assurances that such costs and/or shipping disruptions will not continue to increase.
We are subject to volatility in the price and availability of natural gas, as well as other sources of energy. Such volatility could be intensified by geopolitical tensions, including war and terrorism, as well as other disruptions and market reactions to such events. From time to time, we may use forward purchase contracts or financial instruments to moderate the volatility of a portion of our energy costs. The success or failure of any such transactions depends on a number of factors, including our ability to anticipate and manage volatility in energy prices, the general demand for fuel by the manufacturing sector, seasonality and the weather patterns throughout the United States and the world.
The prices of other commodities such as paper, plastic resins, synthetic rubber and steel significantly influence the costs of packaging, replacement parts and equipment we use in the manufacture of our products and the maintenance of our facilities. Similarly, transportation prices impact our cost of packaging and raw materials we purchase, as well as our cost to deliver finished products to our customers. We have also experienced increases in prices of non-commodity materials we purchase. As a result, increases in the prices of commodities, transportation and other materials may increase our cost of sales and present the same types of risks as described above.
To the extent that we experience increased costs in any of these areas, we may increase our prices, pass the increases along to customers, or otherwise take actions to offset the impact. Further, competitive pressures and other factors may also limit our ability to quickly raise prices in response to increased costs. Accordingly, we may not be able to offset increased costs fully or at all, and there can be no assurances that increasing prices will fully mitigate the impact of these increases, which could adversely impact our results.
Our business could be negatively affected by supply, capacity, labor, information technology, logistics and other disruptions or the costs incurred to avoid these disruptions.
Supply, capacity, information technology and logistics disruptions (which may be caused by a variety of factors, including public health crises such as the COVID-19 outbreak or other outbreaks of diseases or illnesses, weather conditions, governmental controls, tariffs, national emergencies, natural or man-made disasters, other force majeure events, abrupt political change, terrorist activity and armed conflict, or other similar events) or our failure to mitigate such disruptions could adversely affect our ability to manufacture, package or transport our products or require additional resources to maintain or restore our supply chain. In addition, labor shortages or an increase in the cost of labor could adversely affect our profit margins and results of operations. As a result of the COVID-19 pandemic, there could be continued or renewed restrictions on our ability to travel or disruptions in our supply chain or ability to manufacture our products, as well as temporary closures of our facilities or those of our suppliers or customers, any of which could impact our sales and operating results. Some of our products require raw materials and/or packaging that are provided by a limited number of suppliers, or are demanded by other industries or are simply not available at times. Problems or delays experienced by these suppliers as a result of labor shortages or other events could lead to shortages in our production capacity, which could impact our ability to meet customer demand. In addition, as we grow or experience increased customer demand, our existing suppliers may not be able to meet our increasing demand, and we may need to find additional suppliers. We may not be able to secure suppliers who provide materials at, or services to, the specification, quantity and quality levels that we demand (or at all) or be able to negotiate acceptable fees and terms of services with any such suppliers. Additionally, such disruptions have resulted in challenges in addressing or backlogs and further backlog could develop in the event of continued disruptions.
Further, some of our products are manufactured on equipment at or near its capacity thus limiting our ability to sell additional volumes of such products until more capacity is obtained. Additionally, as with all manufacturing facilities, equipment and infrastructure age and become subject to increasing maintenance and repair and the costs associated with such maintenance and repair may be significant. We have experienced increased costs and shortages in repair parts and our ability to procure components to repair equipment essential for our manufacturing processes could also be negatively impacted by various restrictions or disruptions in supply chains, among other items. In addition, an increase in truck or ocean freight costs may reduce our profitability, and a decrease in transportation availability may affect our ability to deliver our products to our customers and consequently decrease customer satisfaction and future orders. See “Increases in energy, commodity and transportation costs would increase our operating costs, and we may be unable to pass all these increases on to our customers in the form of higher prices and surcharges” for additional risks related to increased transportation costs and logistics disruptions. Disruptions arising from the foregoing or other events could adversely impact our results.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
During the three months ended January 31, 2022, we did not sell any securities which were not registered under the Securities Act of 1933. The following chart summarize our Common Stock and Class B stock purchases during this period. There are no shares of our Class A Common Stock currently outstanding.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
ISSUER PURCHASES OF EQUITY SECURITIES1, 2 |
| | (a) | | (b) | | (c) | | (d) |
For the Three Months Ended January 31, 2022 | | Total Number of Shares Purchased3 | | Average Price Paid per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Maximum Number of Shares that may yet be Purchased Under Plans or Programs4 |
Common Stock |
November 1, 2021 to November 30, 2021 | | 12,691 | | $34.95 | | 10,933 | | 737,654 |
December 1, 2021 to December 31, 2021 | | 303 | | $32.80 | | — | | 737,351 |
January 1, 2022 to January 31, 2022 | | 100,242 | | $34.51 | | — | | 637,109 |
|
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
|
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
1 The table summarizes repurchases of (and remaining authority to repurchase) shares of our Common Stock. Descriptions of our Common Stock, Class B Stock and Class A Common Stock are contained in Exhibit 4.1 to our Annual Report on Form 10-K for the fiscal year ended July 31, 2021 filed with the SEC.
2 The figures in the table reflect transactions according to the settlement dates. For purposes of our unaudited consolidated financial statements included in this Form 10-Q, the impact of these repurchases is recorded according to the settlement dates.
3 Includes 2,061 Common Stock shares surrendered by employees to pay taxes related to restricted stock awards.
4 Our Board of Directors authorized the repurchase of 250,000 shares of Common Stock on June 14, 2012 and an additional 750,000 shares of Common Stock on March 11, 2019. These authorizations do not have a stated expiration date. Our Board of Directors authorized the repurchase of 300,000 shares of Class B stock on March 21, 2018. The share numbers in this column indicate the number of shares of Common Stock that may yet be repurchased under these authorizations. Repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing, number and manner of share repurchases will be determined by our management.
ITEM 4. MINE SAFETY DISCLOSURES
Our mining operations are subject to regulation by the Mine Safety and Health Administration under authority of the Federal Mine Safety and Health Act of 1977, as amended. Information concerning mine safety violations or other regulatory matters required by section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K is included in Exhibit 95 to this Quarterly Report on Form 10-Q.
ITEM 6. EXHIBITS
| | | | | | | | | | | | | | |
Exhibit No. | | Description | | SEC Document Reference |
| | | | |
10.1 | | | | Incorporated by reference to Exhibit 10.1 to Oil-Dri's (file No. 001-12622) Current Report on Form 8-K filed on December 17, 2021. |
| | | | |
11 | | | | Filed herewith. |
| | | | |
31 | | | | Filed herewith. |
| | | | |
32 | | | | Furnished herewith. |
| | | | |
95 | | | | Filed herewith. |
| | | | |
101.SCH | | XBRL Taxonomy Extension Schema Document | | Filed herewith. |
| | | | |
101.CAL | | XBRL Taxonomy Extension Calculation Linkbase Document | | Filed herewith. |
| | | | |
101.DEF | | XBRL Taxonomy Extension Definition Linkbase Document | | Filed herewith. |
| | | | |
101.LAB | | XBRL Taxonomy Extension Labels Linkbase Document | | Filed herewith. |
| | | | |
101.PRE | | XBRL Taxonomy Extension Presentation Linkbase | | Filed herewith. |
| | | | |
104 | | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101 | | Filed herewith. |
Note: Stockholders may receive copies of the above listed exhibits, without fee, by written request to Investor Relations, Oil-Dri Corporation of America, 410 North Michigan Avenue, Suite 400, Chicago, Illinois 60611-4213, by telephone at (312) 321-1515 or by e-mail to info@oildri.com.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OIL-DRI CORPORATION OF AMERICA
(Registrant)
BY /s/ Daniel S. Jaffee
Daniel S. Jaffee
Chairman, President and Chief Executive Officer
BY /s/ Susan M. Kreh
Susan M. Kreh
Chief Financial Officer
Dated: March 11, 2022